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ABSTRACT 
 
JENNIFER B. OLIVER 
 
The Prevalence of Nelson Bay Virus in Humans and Bats and Its Significance within the 
Framework of Conservation Medicine 
 
(Under the direction of KAREN GIESEKER, FACULTY MEMBER) 
 
 
Public health professionals strive to understand how viruses are distributed in the 
environment, the factors that facilitate viral transmission, and the diversity of viral agents 
capable of infecting humans to characterize disease burdens and design effective disease 
intervention strategies.  The public health discipline of conservation medicine supports 
this endeavor by encouraging researchers to identify previously unknown etiologic agents 
in wildlife and analyze the ecologic of basis of disease.  Within this framework, this 
research reports the first examination of the prevalence in Southeast Asia of the 
orthoreovirus Nelson Bay virus in humans and in the Pteropus bat reservoir of the virus.  
Contact with Pteropus species bats places humans at risk for Nipah virus transmission, an 
important emerging infectious disease.  This research furthermore explores the 
environmental determinants of Nelson Bay and Nipah viral prevalence in Pteropus bats 
and reports the characterization of two novel orthoreoviruses isolated from bat tissues 
collected in Bangladesh.   
 
 
 
 
INDEX WORDS: Nelson Bay virus, Orthoreovirus, Nipah virus, Emerging infectious 
disease, Conservation medicine, Megachiropterans, Bats, Bangladesh 
 
 
 
 
THE PREVALENCE OF NELSON BAY VIRUS IN HUMANS AND BATS AND 
ITS SIGNIFICANCE WITHIN THE FRAMEWORK OF CONSERVATION 
MEDICINE 
 
 
By 
 
 
 
JENNIFER B. OLIVER 
B.S. UNIVERSITY OF GEORGIA 
 
 
 
 
 
 
 
A Thesis Submitted to the Graduate Faculty of Georgia State University in Partial 
 
Fulfillment of the Requirements for the Degree 
 
MASTER OF PUBLIC HEALTH 
 
ATLANTA, GEORGIA 
 
2007 
 
 
 
 
APPROVAL PAGE 
 
 
The Prevalence of Nelson Bay Virus in Humans and Bats and Its Significance within the 
Framework of Conservation Medicine 
 
 
By 
 
Jennifer B. Oliver 
 
 
 
 
 
 
 
 
 
 
 
Approved: 
 
 
Karen E. Gieseker, PhD, MS 
_______________________________________ 
Committee Chair 
 
 
 
John Steward, MPH 
________________________________________ 
Committee Member 
 
 
 
James A Comer, PhD, MPH 
________________________________________ 
Committee Member 
 
 
 
July 11, 2007 
________________________________________ 
ACKNOWLEDGEMENTS 
 
 
In addition to my thesis committee and other faculty at the Institute of Public Health, I 
owe a debt of gratitude to the following people for their support and contribution to this 
work: 
 
Pierre E. Rollin, MD, James A. Comer, PhD, MPH, and Thomas G. Ksiazek, PhD, DVM 
of the Special Pathogens Branch, National Center for Zoonotic, Vector-Borne and Enteric 
Diseases, Centers for Disease Control and Prevention for their inspiration, technical 
guidance, research expertise, and support of my educational endeavors during my 
employment.  Thank you so much for granting me the time to research this project and to 
pursue this degree. 
 
R. W. Compans of Emory University for donating a working stock of the Nelson Bay 
virus prototype strain. 
 
Cynthia M. Goldsmith, MS of the Infectious Disease Pathology Branch, National Center 
for Zoonotic, Vector-Borne and Enteric Diseases, Centers for Disease Control and 
Prevention for the identification of unknown viral isolates and for training in electron 
microscopy techniques. 
 
Darrin Carroll, PhD, MPH, Joel Montgomery, PhD, MPH, and the many other 
investigators who collected the specimens from Bangladesh I examined in this screening. 
 
My husband, Brett W. Oliver, for his patience, tireless encouragement, and for making 
sure I didn’t take all my meals out of vending machines. 
 
My parents, John and Nancy Betts, for listening. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
AUTHOR’S STATEMENT 
 
 
In presenting this thesis as a partial fulfillment of the requirements for an 
advanced degree from Georgia State University, I agree that the Library of the University 
shall make it available for inspection and circulation in accordance with its regulations 
governing materials of this type. I agree that permission to quote from, to copy from, or 
to publish this thesis may be granted by the author or, in his/her absence, by the professor 
under whose direction it was written, or in his/her absence, by the Associate Dean, 
College of Health and Human Sciences. Such quoting, copying, or publishing must be 
solely for scholarly purposes and will not involve potential financial gain. It is 
understood that any copying from or publication of this dissertation which involves 
potential financial gain will not be allowed without written permission of the author. 
 
 
 
 
        Jennifer B. Oliver 
_____________________________ 
 
Notice to Borrowers Page 
 
All theses deposited in the Georgia State University Library must be used in accordance 
with the stipulations prescribed by the author in the preceding statement. 
 
The author of this thesis is: 
 
Student’s Name: Jennifer B. Oliver 
 
Street Address: 2883 Country Squire Ln. 
City, State, Zip Code: Decatur, GA, 30033 
 
Professor’s Name: Karen Gieseker 
 
Department: Institute of Public Health 
 
College: College of Health and Human Sciences 
 
Georgia State University 
P.O. Box 4018 
Atlanta, Georgia 30302-4018 
 
Users of this thesis who are not enrolled as students at Georgia State University are 
required to attest acceptance of the preceding stipulation by signing below. Libraries 
borrowing this thesis for the use of their patrons are required to see that each user records 
here the information requested. 
 
 
 
 
Vita 
Name:  Jennifer B. Oliver 
Address:  2883 Country Squire Ln. 
Decatur, GA 30033 
 
Education: 
1999 Bachelor of Science in Microbiology, Bachelor of Science in Genetics, The 
University of Georgia, Athens, Georgia  
 
Professional Experience: 
2003-Present Microbiologist, Special Pathogens Branch, National Center for Zoonotic, 
Vector-Borne and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, 
Georgia 
2002-2003 Orise Fellow, Molecular Pathogenesis Laboratory, Scientific Resources 
Program, Centers for Disease Control and Prevention, Atlanta, Georgia 
2000-2002 Associate, Becton Dickinson Laboratories, Grayson, Georgia 
1999-2000 Technician, Infectious Disease Laboratory, Department of Medical 
Microbiology, University of Georgia, Athens, Georgia 
 
Selected Publications: 
Haynes, L. M., Miao, C., Harcourt, J. L., Montgomery, J. M., Le, M. Q., Dryga, S. A., 
Kamrud, K. I., Rivers, B., Babcock, G. J., Oliver, J. B., Comer, J. A., Reynolds, M., 
Uyeki, T. M., Bausch, D., Ksiazek, T., Thomas, W., Alterson, H., Smith, J., Ambrosino, 
D. M., Anderson, L. J. (2007). Recombinant protein-based assays for detection of 
antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid 
proteins. Clin Vaccine Immunol, 14(3), 331-333. 
Amman BR, Pavlin BI, Albariño CG, Comer JA, Erickson BR, Oliver JB, et al. Pet 
rodents and fatal lymphocytic choriomeningitis in transplant patients. Emerg Infect Dis 
[serial on the Internet]. 2007 May [date cited]. Available from 
http://www.cdc.gov/EID/content/13/5/719.htm 
Carroll, D. S., Niezgoda, M., Montgomery, J. M., Kuzmin, I., Keeler, N., Gurley, E., 
Hossain, J., Azad, A. T., Mills, J., Ksiazek, T., Rollin, P., Comer, J. A., Oliver, J. B., 
Rupprecht, C., Akram, K., Croisier, A., Formenty, P., Bertherat, E., Breiman, R. F. 
(Publication in Preparation). Zoonotic Transmission of Nipah virus in Central 
Bangladesh. 
 TABLE OF CONTENTS 
 
   Page
ACKNOWLEDGEMENTS iii
    
LIST OF FIGURES vii
        
LIST OF TABLES viii
    
CHAPTER  
I. INTRODUCTION 
  Background 1
  Research Rationale 5
  Hypotheses 7
    
II. LITERATURE REVIEW 
  
The Environmental Determinants of Zoonotic Infectious 
Disease Emergence 10
  
Bats: Important Zoonotic Carriers of Emerging Infectious 
Diseases 14
  Bat Taxonomy and Ecology 16
  Paramyxoviruses in Pteropus Bats 18
  The Epidemiology of Nipah Virus 19
  
Patterns of Transmission in the First Nipah Virus Outbreak: 
Malyasia and Singapore, 1998-99 21
  
After Malaysia: A Chronology of Nipah Virus Transmission in 
Later Outbreaks: 22
   The 2001 Indian Outbreak 23
   The Bangladeshi 2001 and 2003 Outbreaks 24
   The Bangladeshi 2004 Outbreak 24
   The Bangladeshi 2005 Outbreak 26
  
A Summary of the Transmission Patterns in the Nipah Virus 
Outbreaks 26
  The History of Nelson Bay (NB) Virus 29
  
Nelson Bay (NB) Virus Research Opportunities and Their 
Public Health Significance 30
  
The Importance of Disease Surveillance in Bats within the 
Framework of Conservation Medicine 34
 
 
iv 
    Page
III. METHODOLOGY  
  Study Description 37
  Independent Variables Examined and Tests of Significance 40
  Characteristics of the Human Specimen Collection 42
  Characteristics of the Bat Sera Collection 43
  Laboratory Methods 46
   
Nelson Bay (NB) Virus and Unknown Virus Isolation 
Techniques 46
   Electron Microscopy of Unknown Virus Isolates 47
   
Nelson Bay (NB) Virus Mouse Hyperimmune Ascitic Fluid 
(HMAF) Production 47
   Indirect Nelson Bay (NB) Virus IgG EIA Development 48
   Nelson Bay (NB) Virus Serum Neutralization Assays 49
     
IV. RESULTS   
  Nipah Virus Seroprevalence Patterns in the Human Specimen Collection 51
  Nipah Virus Seroprevalence Patterns in the Bat Sera Collection 52
  Nelson Bay (NB) Virus EIA Serology Results 55
  Nelson Bay (NB) Virus Serum Neutralization Assay Results 57
  Nelson Bay (NB) Virus Seroprevalence Patterns in the Bat Sera Collection 58
  
Nipah and Nelson Bay (NB) Virus Seroprevalence Pattern Similarities in 
the Bat Sera Collection 58
   With Respect to Bat Gender 62
   With Respect to Mean Bat Body Measurements 63
   With Respect to Bat Roost Location 66
  Virus Isolation Results 69
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
   Page
V. DISCUSSION AND CONCLUSION  
  Implications of the Virus Isolation Results 71
  
Interpretation of the Nipah Virus Seroprevalence in the Human Specimen 
Catalog 73
  Interpretation of the Nipah Virus Seroprevalence in the Bat Sera Catalog 74
  Implications of the Nelson Bay (NB) Virus EIA Results 76
  
Interpretation of the Nipah and Nelson Bay (NB) Virus Seroprevalence 
Pattern Similarities 78
    With Respect to Bat Mean Body Measurements and Bat Gender 80
    With Respect to Bat Roost Location 82
  The Public Health Importance of the Results of this Research 84
  The Environmental Determinants of Bat Viral Prevalence 86
  Limitations of the Study 90
  Recommendations 91
  Conclusion 93
     
REFERENCES 95
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF FIGURES 
 
 
Figure  Page
1 The Host Ecological Continuum 12 
2 Map of the Distribution of Pteropus Fruit Bats 17 
3 Map of Nipah and Hendra Virus Outbreak Locations 20 
4 
Map of the Nipah Virus Outbreak Locations in Bangladesh and 
India 23 
5 Distribution of the Nipah Virus Antibody Positive Bats by Species 55 
6 
Human Nelson Bay (NB) Virus EIA Sum OD Frequency 
Distributions 56 
7 Bat Nelson Bay (NB) Virus EIA Sum OD Frequency Distributions 57 
8 Map of the Bat Roost Locations 68 
9 Map of the Bat Orthoreovirus Isolates 71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
LIST OF TABLES 
 
 
Table  Page
1 
Summary of Human Outbreaks Caused by Paramyxoviruses Maintained 
in Bat Reservoirs 28 
2 Characteristics of the Human Specimen Catalog 43 
3 Characteristics of the Bat Sera Catalog 44 
4 Species Distribution of the Bat Sera Catalog 45 
5 Distribution of the Human Sera Screened by Specimen Group 52 
6 Distribution of the Bats Sera Screened by Specimen Group 53 
7 
Distribution of the Nipah or Nelson Bay (NB) Virus Seropositive Bat 
Specimens by Species 60 
8 
Nelson Bay (NB) Virus Seroprevalence by Gender in the R. 
leschenaulti bats 62 
9 Nipah Virus Seroprevalence by Gender in the P. giganteus bats 63 
10 R. leschenaulti and P. giganteus Mean Body Measurements 64 
11 
Independent T-test of Mean Forearm Length and Weight in P. 
giganteus Males 65 
12 Independent T-test of Mean Forearm Length in R. leschenaulti Females 65 
13 Nipah and Nelson Bay (NB) Virus Seroprevalence by Bat Roost 67 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 Chapter 1: Introduction 
 
 
Background: 
 
The U.S. Surgeon General infamously proclaimed in a speech to Congress in 
1969 “it’s time to close the book on infectious diseases.”  Recent generations of public 
health professionals have often marveled at this oversight while struggling to respond to a 
diverse range of new infectious agents and disease etiologies (Fauci, 2001).  As 
summarized in a 2004 Nature Medicine Supplement article by Weiss and McMichael, the 
Institute of Medicine’s landmark report in 1992 (IOM Report,1992) described diseases 
that are “caused by a newly evolving or newly occurring infection, established infectious 
diseases undergoing increased incidence or geographic spread, or newly discovered 
infectious agents causing a known infectious disease” as emerging infectious diseases 
(EIDs) (Weiss & McMichael, 2004, p. S70).  First proposed by Taylor et al., many 
authors acknowledge that almost fifty percent of all human infections are due to diseases 
considered EIDs such as drug resistant tuberculosis and HIV/AIDS (Taylor et al., 2001).  
In addition, Feldmann et al. reiterated that societies around the globe are threatened by 
the at least 50 new diseases that have emerged in the past 20 years according to the 
Centers for Disease Control and Prevention (CDC) and the World Health Organization 
(WHO) (Feldmann et al., 2002; McMichael, 2004).  EIDs comprise a significant threat to 
public health and as a result, interest in EID research has grown during the past decades 
(Lederberg et al., 1992; Newman et al., 2005).    
It is a widely accepted view of EID researchers that few EIDs exclusively affect a 
single host; instead, most emerging diseases exist within a host continuum capable of 
infecting wildlife, domestic animals, and humans (Daszak et al., 2000, , 2001; Daszak et 
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 al., 2004; Kruse et al., 2004).  Approximately 75% of EIDs are of zoonotic origin and 
hence transmitted from animals to humans either directly or via an arthropod vector 
(Taylor et al., 2001).  Therefore, the ecologic or environmental factors affecting either the 
zoonotic or human host play a particularly important role in the emergence or re-
appearance of these diseases (Daszak et al., 2004; Feldmann et al., 2002; Kruse et al., 
2004).   
Cleaveland and colleagues recently categorized all known pathogens of humans, 
domestic livestock, and domestic carnivores based on the ability of the pathogen to jump 
species.  They found that out of the 1,415 known human pathogens, a considerable 61.6% 
have a domestic animal origin (Cleaveland et al., 2001).   It would be an enormous 
undertaking to add to this catalog a listing of wildlife pathogens capable of infecting 
humans in addition to the domestic animal sources examined.  Moreover, since scientists 
estimate that only around one percent of the total number of human pathogens found in 
wildlife are known, such a listing would be woefully inadequate (Morse, 1993; Torres-
Velez & Brown, 2004).   
In the absence of vaccines, zoonotic disease control measures are largely directed 
at preventing zoonotic disease spread from animal or arthropod vectors to humans.  
However, characterizing the underlying determinants that affect disease prevalence in 
wildlife, performing surveillance in zoonotic disease hosts, and the identification of 
previously unknown infectious agents in wildlife are also critical components of zoonotic 
disease prevention (Daszak et al., 2004; Dobson, 2005; Kruse et al., 2004; Lynn et al., 
2006; Steele, 1985; van der Poel et al., 2006).  An increase in the prevalence of a virus in 
a zoonotic host reservoir may trigger a spillover event that results in human disease 
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 (Calisher et al., 2006; Daszak et al., 2000).  Although officials acknowledge that newly 
emerged novel zoonotic agents have often threatened public health, few studies have 
attempted to identify unknown agents in wildlife (Breed et al., 2005; Calisher et al., 2006; 
Daszak et al., 2004; Halpin et al., 2007; Steele, 1985; S. Wong et al., 2006).  Specifically, 
the ecologic conditions that precipitate the transmission of pathogens harbored by 
mosquitoes and other insects, ticks, snails, rodents, and bats are repeatedly identified by 
scholars as one of  the most important areas of human EID research (Morens et al., 2004; 
Zinsstag et al., 2007).   
Although bats are most often incriminated in the transmission of rabies and other 
lyssaviruses, bats also play a lesser-known role in the transmission of such devastating 
human viral illnesses as SARS, Ebola and Marburg, West Nile, Kyasanur Forest disease, 
Japanese Encephalitis, Chikungunya, Venezuelan equine encephalitis, Hantaan, Rift 
Valley fever, and Influenza A (Breed et al., 2005; Calisher et al., 2006; Dobson, 2005; 
Halpin et al., 2007; van der Poel et al., 2006).  Yet surprisingly, the  full diversity of the 
bat viral landscape, sometimes referred to as bat viral ecology, remains undiscovered 
(Breed et al., 2005; Calisher et al., 2006; Halpin et al., 2007; S. Wong et al., 2006). 
Nipah viral encephalitis is a newly recognized zoonotic EID which has caused 
outbreaks of severe encephalitis in humans throughout Southeast Asia since 1999 (Chua 
et al., 1999) and is transmitted to humans from bats either directly or via an animal 
intermediary (Field et al., 2001; Parashar et al., 2000; Yob et al., 2001).  Infections 
caused by many of the bat-transmitted EIDs, such as Nipah virus encephalitis, are rare 
relative to the morbidity and mortality caused by other infectious disease threats to public 
health.  Nevertheless, bat-transmitted EIDs remain threatening due to their high case 
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 fatality ratios, lack of effective therapy, public dread, threat to the agricultural industry, 
and potential bioterrorism use (Daszak et al., 2004; Feldmann et al., 2002; Lederberg et 
al., 1992; McMichael, 2004; Newman et al., 2005).   
Researchers have proposed that the frequency of Nipah virus outbreaks in 
Southeast Asia may be increasing due to environmental pressures, many of which are the 
result of human actions (Chua, Chua et al., 2002; Daszak et al., 2001; J. H. Epstein et al., 
2006; Weiss & McMichael, 2004).  Furthermore, some researchers believe that EID 
zoonoses often occur in unhealthy ecosystems since zoonotic EIDs have strong 
environmental determinants (Alcamo et al., 2003; Cook et al., 2004).  These 
environmental determinants might likewise increase the prevalence of other viruses 
maintained in bat reservoirs not yet associated with human or wildlife disease (Daszak et 
al., 2001; van der Poel et al., 2006).  An increase in the prevalence of a known viral agent 
in bats may provide an early warning indicator of the existence of favorable conditions 
that could likewise precipitate spillover of an unknown bat virus into humans.  Therefore, 
monitoring the bat prevalence of viruses causing known disease in humans, like Nipah 
virus, may also serve as a surrogate measure of overall ecosystem health (Alcamo et al., 
2003; Cook et al., 2004).   
The prevalence of zoonotic diseases in human and animal hosts is commonly 
determined based on antibody evidence of viral infection by serology.  Enzyme-linked 
immunosorbant assays (EIAs) have been developed to test for antibodies in bats and 
humans against EIDs such as SARS, Nipah, Hendra, and Ebola because they provide a 
quick and cost-effective way to determine exposure (Daniels et al., 2001).  Previous 
research has demonstrated that Nelson Bay (NB) virus and other newly discovered 
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 viruses from the orthoreovirus family are circulating in bats of the Pteropus genus in 
Southeast Asia and Australia.  However, the prevalence of these viruses in their bat hosts 
remains unknown (Chua et al., 2001; Dixon, 2007; G. P. Gard & Marshall, 1973; Halpin 
et al., 2007; Pritchard et al., 2006; S. Wong et al., 2006).  In fact, NB virus has been 
studied so little that fewer than a dozen papers have ever referenced it in the literature 
since it was first detected in 1970 (G. Gard & Compans, 1970).  Although bat 
orthoreoviruses, like NB virus, are currently not suspected to be agents of human disease, 
screening for antibody evidence of NB virus has not been attempted.  No diagnostic assay 
currently exists to detect the presence of NB virus.  A serologic assay to detect antibody 
to NB virus may be a useful diagnostic tool if NB virus were to cross species barriers to 
cause disease in domestic animals, wildlife, or humans.   
 
Research Rationale: 
The environmental determinants affecting the prevalence of Nipah virus in bats 
from Southeast Asia might similarly be affecting the prevalence of NB virus since both 
viruses share a common reservoir, bats of the genus Pteropus.  With a geographic 
distribution that spans Southeast Asia and Australia, some Pteropus bats share a high 
degree of contact in camps of overlapping species (Wilson & Reeder, 2005).  If NB virus 
is shed in the bodily fluids of Pteropus bats, as has been documented for Nipah virus 
(Chua, Koh et al., 2002), it is possible that NB virus would be efficiently transmitted to 
other cohabitating bat species so that it is found throughout the geographic distribution of 
Pteropus bats.    
 5
 Developing an EIA assay to detect NB viral antibody would allow researchers to 
explore the seroprevalence of NB virus.  Determining the seroprevalence of NB virus in a 
bat sera catalog containing known antibody evidence of Nipah viral infection may 
elucidate temporal or geographic similarities in the prevalence patterns of both viruses.  If 
pattern similarities are identified, they may help researchers better characterize the role 
that environmental determinants play in affecting the prevalence of bat viruses.  To 
explore these hypotheses, a NB virus EIA was developed to screen a collection of over 
2,323 rare bat sera specimens collected throughout Southeast Asia from 1993 through 
2006.  The bat sera specimens were previously determined to have antibody evidence of 
Nipah virus infection and were tested for NB viral antibody to better understand the 
distribution of this unexplored bat virus.  
To further characterize the viral ecological spectrum in bats, which are important 
disease host, 168 bat liver and spleen tissue specimens associated with a 2004 
Bangladeshi human Nipah virus outbreak from eight bat species were screened for the 
presence of virus by cell culture.  Although previous studies have indicated that most 
novel viruses identified are unlikely to be of direct significance to human or animal 
health, novel nonpathogenic virus isolates may nevertheless help describe the full 
diversity of the viral ecologic spectrum in bat reservoirs of human disease (Calisher et al., 
2006; Halpin et al., 2007). 
The Southeast Asian human populations that experienced outbreaks of Nipah 
virus have unique environmental, lifestyle, and behavioral attributes that may have 
resulted in their exposure to other bat-transmitted viruses.  It is unknown if the 
environmental, lifestyle, and behavioral risk factors present in the Southeast Asian 
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 populations that experienced outbreaks of Nipah virus also exposed the populations to 
NB virus.  Although bat orthoreoviruses, like NB virus, are currently not suspected to be 
agents of human disease, screening for antibody evidence of NB virus has not been 
attempted.  Screening a Nipah virus outbreak associated human sera catalog previously 
tested for Nipah viral antibody may therefore lead to the identification of other bat 
viruses previously unknown in humans, like NB virus.  Therefore, 1,861 human patient 
specimens collected during Nipah virus outbreaks in Southeast Asia from 2001 through 
2006 and previously tested for Nipah viral antibody were also screened for NB virus 
using the newly developed EIA.   
Traditional epidemiological research has focused on identifying risk factors 
specific to human disease.  Larger ecologic trends influencing disease emergence on a 
global scale are often unrecognized (Farmer, 1996; Lederberg et al., 1992).  The newly 
acknowledged public health discipline of conservation medicine encourages a 
macroscopic approach to disease study by examining the underlying ecologic causes of 
disease emergence using multidisciplinary techniques often considered outside the 
confines of the both the conventional analytic and social sciences (Daszak et al., 2001).  
Conservation medicine strives to examine the full diversity of pathogens in important 
wildlife reservoirs of human disease to elucidate the factors that precipitate EID spillover 
from wildlife to humans (Daszak et al., 2004; Weinhold, 2003).   
 
Hypotheses: 
Within the framework of conservation medicine, this research hypothesizes (1) 
that culturing the 168 bat liver and spleen tissues collected during the 2004 Bangladesh 
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 Nipah virus outbreak will result in the identification of novel viral agents.  If the outcome 
of this research supports hypothesis (1), the discovery of novel viral agents in bat 
reservoirs of disease may help researchers identify the environmental factors and viral 
characteristics that separate the viruses that cause disease in humans from the larger pool 
of bat viruses that do not.  Since novel bat-transmitted viruses have often threatened 
public health, it is important to explore the full diversity of viruses present in bats.   
It is further hypothesized that (2) screening a bat sera catalog previously tested for 
Nipah viral antibody with a newly developed NB virus immunoassay (EIA) will result in 
the successful detection of NB viral antibody among the bat species in the sera catalog 
known to carry Nipah viral antibody.  If the results of this work support hypothesis (2), 
temporal or geographic similarities in the seroprevalence patterns of both viruses may be 
identified in bats.  Prevalence pattern similarities may indicate the existence of larger 
environmental risk factors affecting the prevalence of bat viruses.  An increase in the 
prevalence of a bat viral pathogen may also represent an increased risk that the virus will 
be zoonotically transmitted to humans.  Therefore, similarities in the seroprevalence 
patterns of Nipah and NB viruses may results in the identification of risk factors for the 
occurrence of human disease.   
Environmental determinants increasing the prevalence of known viruses in bats 
may be similarly affecting the prevalence levels of viruses yet to be discovered, 
representing an unquantifiable disease risk to human and veterinary public health (van 
der Poel et al., 2006).  Large scale environmental risk factors of disease may promote the 
transmission of a range of pathogenic disease agents to humans from many wildlife 
sources.  Since ecologists propose that zoonotic EIDs have strong environmental 
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 determinants and EIDs often occur in unbalanced ecosystems, patterns in the prevalence 
of bat viruses may also be markers of unhealthy ecosystems.  Identifying the 
environmental factors that may affect human disease risk from bat-transmitted viruses 
and monitoring changes in bat-viral prevalence may allow public health researchers to 
identify intervention opportunities to prevent human disease outbreaks and to target EID 
surveillance strategies to appropriate high-risk environments.   
Finally, since bat orthoreoviruses are not known agents of human disease, it is 
hypothesized that (3) the newly developed EIA will not detect NB viral antibody in the 
catalog of human specimens previously screened for Nipah viral antibody, although 
screening for NB viral antibody in humans or bats has not been previously attempted.  It 
is unknown if NB virus is capable of infecting humans.  However, the environmental, 
lifestyle, and behavioral attributes of the Southeast Asian settlements that experienced 
Nipah virus outbreaks may have also exposed these populations to NB virus since both 
viruses are maintained in Pteropus bat reservoirs in the region (Halpin et al., 2007).  If 
the results of this research support hypothesis (3), it will lend evidence to the supposition 
that NB virus is not capable of infecting humans despite contact with the bat reservoir of 
NB virus.  It may therefore be concluded that NB virus is not a likely human disease-
causing agent.  Understanding the range of viral agents capable of causing human disease 
is important to public heath officials investigating disease outbreaks of unknown 
etiology.  
 9
 Chapter II: Literature Review 
 
The Environmental Determinants of Zoonotic Infectious Disease Emergence:  
 
 Less developed countries often bear a disproportionate burden of infectious 
disease morbidity and mortality (Infectious Diseases Society of America., 1992).  By 
citing statistics presented in WHO’s World Health Report: 2004 (WHO Report, 2004), 
Fauci et al. noted in 2005 in Emerging Infectious Diseases that contrary to previous 
forecasts,  
“…the worldwide impact from infectious diseases remains 
substantial…[a]lthough annual deaths and lost years of healthy life from 
infectious diseases have decreased over the past decade, …infectious 
diseases remain the third leading cause of death in the United States each 
year and the second leading cause of death worldwide” (Fauci et al., 2005, 
p. 519).   
 
In 2003, a landmark study by the Institute of Medicine (IOM) attributed infectious 
disease emergence to several specific risk factors (Smolinski et al., 2003).  According to 
a 2004 article in Nature by Morens et al., these risk factors have “social, political, 
economic, biological, environmental and genetic features” and are defined by the 
following list:  
“microbial adaptation and change, human susceptibility to 
infection, climate and weather, changing ecosystems, economic 
development and land use, human demographics and behavior, technology 
and industry, international trade and commerce, the breakdown of public 
health measures, poverty and social inequity, war and famine, lack of 
political will, and intent to harm” (Morens et al., 2004, p. 245).   
 
Davis and colleagues acknowledge in their Summary and Assessment of the 2001 IOM 
workshop on the International Aspects of Emerging Infections that “[m]any of these 
factors lie outside the purview of the health sector, making it difficult to mitigate their 
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 impact on the transmission of infectious diseases and requiring coordinated approaches 
among various sectors of society for their successful control” (Davis et al., 2001, p. 7).   
Morens and colleagues provided an eloquent summary of one of the basic tenets 
of infectious disease epidemiology, represented by the epidemiologic triangle, in their 
2004 article in Nature.  They point out that “[infectious disease] emergence results from 
dynamic interactions between rapidly evolving infectious agents and changes in the 
environment and in host behaviour that provide such agents with favourable new 
ecological niches” (Morens et al., 2004, p. 242).  Daszak et al. explore the determinants 
of EIDs further in their 2000 article in Science.  They emphasize that complex relations 
exist between humans, domestic animals, and wildlife.  These relations drive disease 
emergence and “many wildlife species are reservoirs of pathogens that threaten domestic 
animal and human health” (Daszak et al., 2000, p. 443).  Now considered by many 
researchers as a basic paradigm of zoonotic EID study, human and wildlife diseases are 
interdependent, as exemplified by Daszak et al.’s model of the host ecological 
continuum, depicted in Figure 1 from their 2000 Science article (Daszak et al., 2000, p. 
443).     
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Figure 1.  The Host Ecological Continuum.  Domestic animal, human, and 
wildlife EIDs are interdependent and are affected by the factors listed under the 
arrows. Daszak lists human encroachment, ecological manipulation, and ex situ 
contact as the factors that enable transmission of infectious agents between 
wildlife and humans  (Daszak et al., 2000, Fig 1, p. 443, Science). 
 
Daszak et al., in addition to many other authors, credit Morse for establishing in 
his 1993 seminal book Emerging Viruses (Morse, 1993) that most human EIDs result 
from the zoonotic transmission of infectious agents from wildlife and that wildlife 
therefore provide a “vast zoonotic pool” of potential human pathogens (Daszak et al., 
2004).   The rate of EID transmission to humans may be accelerated by environmental 
changes, some of which are of human or anthropogenic origin (Daszak et al., 2001; Kruse 
et al., 2004; Lederberg et al., 1992; McMichael, 2004).  A WHO Millennium Ecosystem 
Assessment Working Group on Land Use Change and Infectious Disease Emergence that 
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 convened in 2002 ranked the top environmental changes of human origin contributing to 
EIDs (Alcamo et al., 2003; Patz et al., 2004).  As cited in a 2004 Philosophical 
Transactions of the Royal Society article by McMichael, the Working Group ranked the 
following factors in descending order according to the impact they have on EIDs:  
“agricultural development, urbanization, deforestation, population 
movement, introduced species, biodiversity loss, habitat fragmentation, 
water and air pollution, road building, impacts of HIV/AIDS, climactic 
changes, and hydrological changes (including dams)” (McMichael, 2004, 
p. 1054).   
 
As outlined below, Patz and colleagues described the means by which 
environmental determinants affect EIDs (Patz et al., 2004).  Land use changes often lead 
to the destruction of wildlife habitats that were once isolated from human populations.   
This, in turn, results in an exponential growth in human-wildlife interaction and thereby 
provides exposure to new pathogens for livestock, wildlife, and ultimately, humans 
(Breed et al., 2005; Chomel et al., 2007; Daszak et al., 2001; Lederberg et al., 1992; Patz 
et al., 2004).  
Deforestation also results in a loss of biodiversity and creates small, genetically 
homogenous subpopulations of species that are immunologically more susceptible to 
infectious disease insult (Daszak et al., 2001).  Driven by the increasing demands of the 
human population, global deforestation and habitat encroachment continue at a rate of 
nearly three percent each year (Patz et al., 2004).   
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 Daszak et al. assert in their 2001 review article in Acta Tropica that such land use 
changes 
 “act within a background of pathogen evolution to allow increased 
transmission between individual hosts, increased contact with new host 
populations or species, and selection pressure leading to the dominance of 
pathogen strains adapted to these new environmental conditions” (Daszak 
et al., 2001, p. 104).    
 
Additionally, volatile weather patterns and increasing temperatures may disrupt the 
habitats of disease carrying wildlife or predatory species that check the spread of disease 
vectors, leading to increased concentrations of potential wildlife disease carriers (Patz, 
2002).  It’s often said that “nature abhors a vacuum,” and so, infectious diseases emerge 
in favorable ecological niches created by the dynamic interactions between rapidly 
evolving infectious agents, changes in the environment, and host behavior (Feldmann et 
al., 2002; Morens et al., 2004).  
 
Bats-Important Zoonotic Carriers of Emerging Infectious Diseases: 
Bats are the third most widely distributed land mammals behind rodents and 
humans and the approximately 925 species of bats make up around 20% of the 4,600 
recognized living mammalian species (Calisher et al., 2006; Halpin et al., 2007; 
Mackenzie et al., 2003; Torres-Velez & Brown, 2004; S. Wong et al., 2006).  Bats serve 
as reservoirs or hosts of several emerging zoonotic viral diseases in humans.  Although 
rabies (Rhabdoviridae) is controlled in dogs and other animals by vaccination in 
developed countries, in less developed countries bats constitute a major reservoir and 
transmission source for this virus (Favi et al., 2002).  Additionally, bats were identified in 
1996 as the reservoir hosts for two new strains of Australian bat lyssavirus, also in the 
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 Rhabdoviridae family, which cause symptoms indistinguishable from rabies in humans 
(Kuzmin et al., 2006; Warrilow, 2005).   
Bats have been implicated as reservoir hosts of the coronaviruses, the virus genus 
containing the etiologic agent of SARS (Li et al., 2005), and bats are potentially the 
reservoir host of the filoviruses Ebola and Marburg (Leroy et al., 2005).  In addition, bats 
may play a supportive role in the maintenance or transmission cycles of the following 
vector borne viruses: the flaviviruses West Nile virus, Kyasanur Forest Disease, and 
Japanese Encephalitis; the alphaviruses Chikungunya virus and Venezuelan equine 
encephalitis virus (Mackenzie et al., 2003); and the bunyaviruses,  Rift Valley fever 
virus, and Kaeng Khoi (Osborne et al., 2003).  Bats also serve as animal intermediaries of 
other zoonotic diseases like influenza A virus (Calisher et al., 2006).  Investigating the 
transmission patterns of these viruses using improved diagnostic techniques has lead to 
the discovery of other bat viruses not yet associated with human disease, including the 
paramyxovirus Tioman virus (Chua et al., 2001) and the orthoreovirus Pulau virus 
(Prichard et al., 2006). 
Like the lyssaviruses, many bat viruses causing zoonotic EIDs have ancient viral 
ancestors that coevolved with the predecessors of the bat reservoirs in existence currently 
(Calisher et al., 2006; Newman et al., 2005).  Since several of the cellular receptors and 
metabolic pathways used by bat viruses were evolutionarily conserved in mammals as 
species diverged, many viruses maintained in bat reservoirs are biologically capable of 
interspecies transmission (Breed et al., 2005; Calisher et al., 2006; Newman et al., 2005).   
Furthermore, bats exhibit migratory patterns and crowded roosting behaviors that provide 
opportunities for viruses to spread among bat carriers (Calisher et al., 2006).  
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 Experimental infection studies indicate that bats may develop latent viral infections in 
which viral shedding persists even during seasonal hibernation (Philbey et al., 1998).  
Combined with their extremely long lifespan (up to 35 years for some bat species), 
considerable geographic distribution, and diversity in preference of habitat, bats are 
excellent reservoirs for a variety of viruses (Calisher et al., 2006; Halpin et al., 2007; 
Mackenzie et al., 2003; Torres-Velez & Brown, 2004; S. Wong et al., 2006). 
 
Bat Taxonomy and Ecology:   
Taxonomists classify bats in the kingdom Animalia, phylum Chordata, class 
Mammalia, and order Chiroptera.  The order Chiroptera is further divided into two 
suborders: Megachiroptera, containing a single family, Pteropodidae (42 genera, 166 
species) and Microchiroptera, containing 16 families (135 genera, 759 species).  The bats 
classified in the single family, Pteropodidae, within the Megachiropteran suborder are 
commonly referred to as flying foxes or Old World fruit bats. The distribution of these 
bats spans southeast Asia, Australia, the Indian Ocean, and the eastern coast of Africa 
(Wilson & Reeder, 2005).  Seventy-nine percent of species in the family Pteropodidae are 
Asian and 21% are African (The Henipavirus Ecology Collaborative Research Group).   
Although much information has been gathered about the role of bats in the 
suborder Microchiroptera (insectivorous and vampire bats) in the maintenance and spread 
of viral disease, the Megachiroptera suborder is less well studied (Halpin et al., 2007; 
Mackenzie et al., 2003).  Megachiropterans are the largest bats in the world, eat fruits, 
flowers, and pollen, and most species navigate at night by eyesight rather than by 
echolocation (Wilson & Reeder, 2005).   
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 Because many of these species have overlapping habitats with broad geographic 
distributions, the potential exists for a Megachiropteran bat to transmit a virus throughout 
a large geographic region with substantial implications for public health (Field et al., 
2001; Torres-Velez & Brown, 2004).  Figure 2 displays the geographic distribution of the 
Megachiropteran Old World fruit bats in the family Pteropodidae.  
 
Figure 2.  Map of the Distribution of Pteropodidae Bats.  
Bats in the Pteropodidae family are in the Megachiropteran 
suborder commonly referred to as Old World fruit bats or 
flying foxes.  Unpublished figure presented with 
permission from Thomas Ksiazek, Special Pathogens 
Branch Chief, CDC, Atlanta. 
 
Thus far, researchers have discovered serologic or antigenic evidence of  at least 
66 viruses in bats to date (Calisher et al., 2006).  Under certain environmental 
circumstances, these viruses cross species barriers, or spillover, to cause zoonotic EIDs in 
both humans as well as domestic and wild animals.  Although many of the viruses are not 
yet associated with known disease in wildlife or humans, the ability of clinical research to 
associate a disease with an etiologic agent often lags behind the detection of that agent.  
We are reminded of this fact by the relatively recent association of a known 
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 metapneumovirus, simply called human metapneumovirus (hMPV), as the causative 
agent of many lower respiratory tract infections in children (Kahn, 2006).  Despite this 
glaring need for more research into bat viral dynamics, bat ecological studies are often 
under-funded and underappreciated (Breed et al., 2005; Calisher et al., 2006; Halpin et 
al., 2007).  
 
Paramyxoviruses in Pteropus Bats: 
Nipah, Hendra, Menangle and Tioman viruses are newly recognized 
paramyxoviruses maintained in Pteropus bat reservoirs.  Nipah, Hendra and 
Menangle viruses are of great public health importance since they cause human 
diseases considered EIDs.  Other notable viruses in the paramyxovirus family 
include mumps, measles, and respiratory syncytial virus.  Nipah and Hendra 
viruses are the only two members of the henipavirus genus of the paramyxovirus 
family.  Nipah virus has caused outbreaks of disease in humans via livestock 
intermediaries in Malaysia (1998) and Singapore (1999) and from direct spillover 
into human populations from Pteropus bats, as is thought to have occurred in the 
recent outbreaks in Bangladesh (2001, 2003-2007) and in India (2001) (Bellini et 
al., 2005; Chadha et al., 2006; Hsu et al., 2004).  Hendra virus is closely related to 
Nipah virus.  Hendra virus, however, has only caused three cases of human 
disease after subjects were exposed to the amplified virus through horse 
intermediaries in Australia in 1995 (Field et al., 2001).    
In addition to Nipah and Hendra viruses, Pteropus bats are also the 
suspected reservoir of the paramyxoviruses Menangle and Tioman viruses.  
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 Menangle virus was first identified in 1998 as the causative agent of an outbreak 
of disease in pigs thought to have caused illness in a cluster of farm workers near 
Sydney, Australia (Philbey et al., 1998).  Conversely, Tioman virus is yet to be 
associated with human illness.  First discovered in Malaysia in 2000 (Chua et al., 
2001), Tioman viral antibodies were recently detected in Pteropodinae bats in 
Madagascar in 2007 (Iehlé et al., 2007), exemplifying the wide geographic 
distribution of Pteropus mediated viruses. 
 
The Epidemiology of Nipah Virus: 
Nipah virus infection causes neurological symptoms in humans leading to 
Nipah viral encephalitic disease.  After a 3 to 18-day incubation period, Nipah 
virus infection usually rapidly progresses from flu-like illness to coma within two 
days and death within ten days of symptom onset (Ksiazek et al., 1999).  Case-
fatality ratios vary from 40-92%.  About a quarter of the observed Nipah-infected 
patients have seizures and about 60% become comatose and may require 
mechanical ventilation, although the full course and spectrum of human disease is 
unknown (American Public Health Association., 2004).  Other than supportive 
care, there is no treatment for Nipah virus infection; however, Chong and 
colleagues noted  improved outcomes in patients given ribavirin during the 
Malaysian outbreak (Chong et al., 2001).    
Figure 3, accessed June 11, 2007 from the online encyclopedia 
Wikipedia.org (http://en.wikipedia.org/wiki/Henipavirus#Nipah_virus), maps the 
locations and the years of the known Hendra and Nipah virus human outbreaks 
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 that occurred in Australia, Bangladesh, India and Malaysia.  It also presents the 
geographic distribution of the Pteropus bat reservoirs of Nipah and Hendra 
viruses.  Hendra and Menangle viruses have only caused one outbreak of human 
disease each, where as Nipah virus outbreaks have often occurred in Southeast 
Asia.  The following sections describe key epidemiological features of the Nipah 
virus outbreaks detailed in chronological order.   
 
Figure 3.  Map of Nipah and Hendra Virus Outbreak Locations.  The 
locations of previous human Nipah virus outbreaks (blue stars) and Hendra 
virus outbreaks (red stars) and the geographic distribution of the Nipah virus 
(blue shading) and Hendra virus (red shading) Pteropus bat reservoirs 
(Henipavirus, www.en.wikipedia.org/wiki/Henipavirus). 
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 Patterns of Transmission in the First Nipah Virus Outbreak: Malaysia and 
Singapore, 1998-1999 
 
In 1998, the first diagnosed outbreak of Nipah virus in Malaysia resulted in 104 
human deaths out of 265 suspected cases, many of which were attributed to occupational 
exposure to infected pigs on pig farms or in slaughterhouses (Feldmann et al., 2002).  
Like humans, infected pigs exhibit primarily neurological symptoms and occasionally 
respiratory distress known as barking cough, which may have contributed to the spread of 
Nipah virus among pigs and from pigs to humans via large droplet aerosol formation (K. 
T. Wong et al., 2002).  Since the virus is easily passed from pigs to humans, more than 
one million pigs were culled during the outbreak, causing great economic distress to the 
local agricultural industry (Feldmann et al., 2002).  Less than a year later, eleven cases 
and one death from Nipah virus occurred in Singapore among abattoir workers exposed 
to infected Malaysian pigs (CDC, 1999; Paton et al., 1999).    
This outbreak is a prime example of the wildlife, domestic animal, and human 
host ecological continuum model presented in Figure 1.  In theory, the transmission of 
Nipah virus from wildlife (Pteropus flying foxes) to domestic pigs occurred due to an 
increased overlap between bat habitats and piggeries in Malaysia.  At the index farm, 
fruit orchards were in close proximity to the piggery, allowing pigs close contact with bat 
urine, feces and partially eaten fruit (Chua, Chua et al., 2002). Subsequent trace back 
investigation revealed that pig transfers between farms initiated new human outbreaks 
and genetic sequencing of virus isolates suggested that as little as two instances of 
spillover from bats to pigs resulted in the successful establishment of infection in pig 
populations (AbuBakar et al., 2004; Field et al., 2001).  Nipah viral antibody was 
subsequently detected in 21 bats from five Pteropodidae species out of 324 Malaysian 
 21
 bats captured near locations where Nipah viral infection was reported in pigs (Yob et al., 
2001).  Furthermore, Nipah virus was successfully isolated from the urine of two 
Malaysian Pteropus bats and from residual bat saliva on a partially eaten piece of fruit 
(Chua, Koh et al., 2002).   
 
After Malaysia: A Chronology of Nipah Virus Transmission Patterns in Later 
Outbreaks: India, 2001 and Bangladesh, 2001-2007 
Five human Nipah virus outbreaks have been reported in Bangladesh 
during the winter months in the years 2001-2007.  Additionally, eleven isolated 
cases of Nipah virus encephalitis have appeared in Bangladesh since 2001 
("WHO-Wkly Epi Record," 2004).  At the time of this writing, researchers are 
investigating two confirmed clusters of Nipah virus infection in the Thakurgaon 
and Gaibandah districts of Bangladesh (S.P. Luby, Personal Communication).  
Some researchers believe the seasonality of the human outbreaks may be linked to 
increased viral shedding during Pteropus bat pregnancy and parturition or to a 
seasonal bat habitat or food source ("WHO-Wkly Epi Record," 2004).  Figure 4 
displays the locations of the human Nipah virus outbreaks that occurred in India 
and Bangladesh from the years 2001-2004.  In Figure 4, Nipah virus outbreaks in 
2004 are shown in red while outbreaks in 2001 and 2003 are indicated in blue.   
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Figure 4.  Map of Nipah Virus Outbreak Locations in Bangladesh and India.  
Outbreaks in red occurred in 2004.  Outbreaks in blue occurred in 2001 and 2003.  
Unpublished figure presented with permission from Joel Montgomery, Special 
Pathogens Branch EIS Officer. 
 
Nipah Virus Transmission in the 2001 Indian Outbreak: 
A 2006 retrospective investigation revealed that Nipah virus caused nine deaths of 
18 suspected human cases of encephalitis in February 2001 at healthcare facility in 
Siliguri, India, near the northern Bangladeshi border.  The investigators of the 
retrospective study attributed the outbreak to nosocomial transmission due to a lack of 
appropriate barrier nursing practices at the healthcare facility (Chadha et al., 2006).  
Healthcare-associated transmission also played a role in the Nipah virus outbreak that 
occurred in Bangladesh in 2004.  
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 Nipah Virus Transmission in the Bangladesh 2001 and 2003 Outbreaks: 
In 2003, a retrospective investigation revealed that in April and May of 2001, 
Nipah virus infection resulted in 9 human deaths of 13 suspected cases in Meherpur, 
Bangladesh.  In January 2003, less than 150 km from Meherpur, 8 fatalities among 12 
suspected human cases occurred in Naogaon, Bangladesh.  Both outbreaks were 
concurrently investigated by the same researchers (Hsu et al., 2004).  They found that 
unlike the Malaysian outbreak, as practicing Muslims, most villagers in these areas did 
not keep pigs as livestock, but wild boars occasionally roamed the villages.  Animal 
serosurveys were conducted as part of the Naogaon investigation.  Interestingly, evidence 
of Nipah virus infection was not detected in pigs, birds, shrews, or rodents; however, two 
of 44 (4.5%) Pteropus giganteus bats collected near the villages were positive for Nipah 
viral antibody.  Contact with bat roosts was epidemiologically linked to Nipah virus 
infection in the Naogaon outbreak while direct person-to-person spread was determined 
to be an important mode of transmission in the Meherpur outbreak (Hsu et al., 2004).   
 
Nipah Virus Transmission in the 2004 Bangladeshi Outbreak: 
In January 2004, the Manikganj and Rajbari provinces of Bangladesh reported 42 
human cases including 14 deaths and, in the following month, the Faridpur province 
reported 27 fatalities among 36 cases ("WHO-Wkly Epi Record," 2004).  Many of those 
infected in the Rajbari province were males under the age of 15.  A case-control study 
conducted in the area revealed that climbing palm trees to gather fruit, a favorite activity 
of local boys, was a statistically significant risk factor for Nipah virus infection in this 
outbreak (Montgomery et al., Publication in Preparation).  Local bats in the area roosted 
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 during the day in non-fruit bearing trees, but were observed foraging for fruit at night 
near patient homes or drinking from clay pots used to collect  palm sap from taps placed 
high in date palm trees to produce a beverage.  Since bats shed Nipah virus in urine and 
saliva, the infected boys likely were exposed to Nipah virus in bat secretions or 
excretions in the fruit trees or from handling or ingesting fruit partially eaten by bats 
(Carroll et al., Publication in Preparation).   
The Nipah virus outbreak in the Rajbari province was unique.  Cases were 
clustered within households; symptom onset for each case within the household clusters 
occurred before the minimum known incubation period of three days.  This suggests that 
the household clusters resulted from a single point-source exposure of all those who 
became symptomatic rather than from person-to-person transmission within the 
household (Montgomery et al., Publication in Preparation).  Furthermore, a greater 
number of cases than controls reported harvesting or drinking date palm sap, though this 
was not statistically significant due to the limited size of the outbreak (Carroll et al., 
Publication in Preparation).  As an important part of this outbreak investigation, 
researchers conducted a Nipah virus seroprevalence study in bats collected near the 
affected villages.  The study revealed that 44% of 109 Pteropus giganteus bats were 
positive for Nipah viral antibody (Carroll et al., Publication in Preparation).   
A second Nipah virus outbreak occurred in Bangladesh in 2004 only a month 
after the outbreak detailed above.  A case-control study of the outbreak in the province of 
Faridpur not only strongly suggested that person-to-person transmission played a 
predominant role in Nipah viral spread, but also that transmission may have occurred in a 
bimodal manor, with some singular cases resulting from direct exposure to an unknown 
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 environmental source (ICDDR, 2004).  While some cases had no known contact or 
association with other patients, two cases reportedly resulted from very short patient 
exposure; specifically, a rickshaw driver became infected after merely transporting a 
patient to a hospital (ICDDR, 2004).  At least six cases in this outbreak manifested a new 
acute respiratory distress syndrome (similar to the “barking cough” syndrome in pigs) not 
previously associated with Nipah virus infection in humans which may have contributed 
to the person-to-person spread of the virus via large droplet formation (ICDDR, 2004).    
 
Nipah Virus Transmission in the 2005 Bangladeshi Outbreak: 
One year later, in January 2005, the Tangail District of Bangladesh experienced 
11 deaths of 12 Nipah viral encephalitis cases (ICDDR, 2005).  A case-control 
investigation revealed that cases had a statistically significant 7.9 times increased odds of 
drinking raw date palm sap juice as compared to controls (OR=7.9, 95%CI=1.6-39, 
P=0.01).  Locals prefer to drink this beverage soon after its collection from date palm tree 
taps before fermentation begins despite the presence of bat excrement often found in the 
collection vessels (Luby et al., 2006).   
 
A Summary of the Transmission Patterns in the Nipah Virus Outbreaks: 
Most striking about the Nipah virus outbreaks described above is that the 
risk factors, symptom manifestations, and modes of spread varied largely even 
though these outbreaks occurred in a relatively narrow period in a localized 
geographic area among human populations with similar characteristics.  Modes of 
Nipah viral spread included amplification due to pig intermediaries combined 
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 with occupational exposure to pigs during slaughter or animal husbandry, food 
borne transmission via beverages made from palm sap, direct person-to-person 
transmission, and environmental point-source exposure to the virus via a yet 
unknown source associated with bats.  Table 1 on the following page summarizes 
the modes of virus spread in each of the bat-transmitted paramyxovirus human 
outbreaks previously described.  One may conclude from the evolving 
epidemiology of the bat-transmitted paramyxovirus outbreaks highlighted in 
Table 1 that these viruses are paradigm EIDs.  For example, researchers uncover a 
new aspect of the spectrum of Nipah viral disease with each successive 
appearance.  Much remains to be studied about the etiology and pathogenesis of 
the bat transmitted paramyxoviruses. 
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 The History of Nelson Bay (NB) Virus: 
 Nelson Bay (NB) virus is similar to the paramyxovirus Tioman virus in the 
respects that NB virus is also maintained in a Pteropus bat reservoir and is also not yet 
associated with any known disease in wildlife or humans.  However, unlike Tioman 
virus, NB virus is grouped in the Reovirdae family of segmented, double-stranded RNA 
viruses.  Reoviruses infect hosts as diverse as humans, pigs, fish, insects, reptiles, and 
plants with few restrictions to the range of species in which reoviruses can replicate. 
There are ten genera in the reovirus family, one of which is the genus orthoreovirus.  The 
genus orthoreovirus is further divided into five species based on host range and the ability 
of the virus to create large, multinucleated fused cells in culture (syncitia formation), 
which is an unusual property among viruses lacking the envelope glycoprotein that 
normally mediates viral cell fusion (Fields et al., 2005).  The five species in the 
orthoreovirus genus include the mammalian orthoreoviruses, avian orthoreoviruses, NB 
virus, baboon orthoreoviruses, and reptilian orthoreoviruses (Wilcox & Compans, 1982).  
With the exception of mammalian orthoreoviruses, the four other species of 
orthoreoviruses generate fusogenic cytopathic effects in cell culture (Fields et al., 2005). 
Avian orthoreoviruses inflict great harm on the poultry industry, while 
mammalian orthoreoviruses are suspected causative agents of meningitis in humans 
(Zhang et al., 2006).  Additionally, researchers are investigating the association between 
mammalian orthoreovirus infection in infants and cholestatic liver disease (Fields et al., 
2005).  In human serosurveys, greater than fifty percent of subjects have demonstrated 
antibody to mammalian orthoreoviruses, with infection often occurring in childhood 
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 (Fields et al., 2005).  The NB orthoreovirus species has not been known to cause disease 
in humans, livestock, or wildlife.  
Nelson Bay (NB) virus was first isolated from the heart blood of a Pteropus 
poliocephalus fruit bat in Australia over 30 years ago (G. Gard & Compans, 1970; G. P. 
Gard & Marshall, 1973).  Until 2005, this viral isolate, named simply NB virus, was the 
sole member of the NB orthoreovirus species and the only known bat orthoreovirus.  In 
2005, Pulau virus was isolated from a Pteropus hypomelanus bat collected from Tioman 
island in Malaysia (Pritchard et al., 2006).  Although it has not been officially 
characterized yet in the scientific literature, a third bat orthoreovirus, Broome virus, has 
purportedly been isolated from a Pteropus alecto bat in Broome, Australia  (Halpin et al., 
2007).  Pulau virus is closely related to NB virus by phylogenic analysis and Pritchard et 
al. propose that Pulau virus should be taxonomically classified within the NB 
orthoreovirus species as Nelson Bay virus-Pulau, or NBV-Pulau (Pritchard et al., 2006).   
 
Nelson Bay Virus Research Opportunities and Their Public Health Significance: 
No diagnostic assay currently exists to detect NB virus.  The prevalence of this 
virus in its bat hosts remains unknown (Chua et al., 2001; Dixon, 2007; G. P. Gard & 
Marshall, 1973; Halpin et al., 2007; Pritchard et al., 2006; S. Wong et al., 2006).  In fact, 
NB virus has been studied so little that fewer than a dozen papers have ever referenced it 
in the literature since it was first detected in 1970 (G. Gard & Compans, 1970).  A 
serologic assay to detect antibody to NB virus may be a useful diagnostic tool if NB virus 
were to cross species barriers to cause disease in domestic animals, wildlife, or humans.  
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 Developing an EIA assay to detect NB viral antibody would allow researchers to explore 
the seroprevalence of NB virus in the Pteropus bat reservoir of the virus.   
Both NB and Nipah viruses share a common reservoir: Pteropus bats in Southeast 
Asia.  If NB virus is effectively transmitted among bat species cohabitating in shared 
roosts, as has been document for Hendra virus, NB virus may be found throughout the 
geographic range of Pteropus bats.  Nipah virus has often been transmitted to humans 
from Pteropus bats in Southeast Asia, but it is not known if NB virus can similarly be 
passed to humans.   
The Southeast Asian human populations that endured the Nipah virus outbreaks 
detailed previously live in environments that overlap with Pteropus bat habitats.  
Ecologists believe that these habitats are being altered by environmental risk factors such 
as climate change, deforestation, and shifting agricultural practices.  As with other EIDs, 
these environmental risk factors may similarly encourage the spread of bat-transmitted 
viral diseases.  In addition, the populations that experienced Nipah virus outbreaks have 
unique behavioral and lifestyle characteristics, such as palm sap consumption and tree 
climbing, which may put them at risk for contracting other viruses maintained in 
Pteropus bat reservoirs.  A human specimen catalog assembled from sera collected 
during the previous Nipah virus outbreaks in Southeast Asia would contain specimens 
with antibody evidence of Nipah virus infection.  Some of the Nipah virus antibody in the 
specimen catalog would be attributable to direct human exposure to Pteropus bats in 
Southeast Asia.  Screening Nipah virus outbreak-associated human sera for NB viral 
antibody would therefore investigate the presumption that NB virus has not yet spilled 
over from Pteropus bats to infect humans, unlike the paramyxoviruses Nipah, Hendra, 
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 and Menangle, which have caused terrible disease outbreaks in the region.  It is important 
for public health officials to be aware of the range of viral agents capable causing human 
disease to effectively investigate outbreaks of unknown etiology. 
The prevalence of NB virus in Pteropus bats has not been explored.  Examining 
the seroprevalence of NB virus in bat species from Southeast Asia known to carry Nipah 
viral antibody may elucidate geographic or temporal similarities in the prevalence 
patterns of both viruses.  If seroprevalence pattern similarities are identified, they may 
indicate that larger environmental risk factors are affecting the prevalence of viruses in 
bats in the region.  Ecologists propose that zoonotic diseases have strong environmental 
determinants and that they often occur in unbalanced ecosystems (Cook et al., 2004).  
Therefore, patterns in the prevalence of bat viruses may also be markers of unbalanced 
ecosystems.  Unbalanced ecosystems may promote the zoonotic transmission of a range 
of pathogenic agents to humans from many wildlife sources (Alcamo et al., 2003).  
Environmental determinants increasing the prevalence of known viral pathogens in bats 
may be similarly affecting the prevalence levels of viruses yet to be discovered that 
represent an unpredictable disease risk to human and veterinary public health (van der 
Poel et al., 2006).  Consequently, identifying the environmental factors that may affect 
bat viral prevalence may allow public health researchers to target bat-transmitted disease 
surveillance strategies to appropriate high-risk environments.  Careful monitoring of bat 
viral prevalence rates may allow public health professionals to identify ecologic risk 
factors for human disease and, ultimately, to develop intervention strategies to prevent or 
mitigate human outbreaks of bat-transmitted diseases.  
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  Pteropus bats in Southeast Asia are the known reservoirs of several viruses such 
as Hendra, Tioman, and Menangle, Nelson Bay, Pulau, and Broome viruses.  Many of 
these viruses were only recently discovered in Pteropus bats.  Other yet unknown viruses 
may be circulating in these disease hosts.  A virus maintained in a Pteropus bat reservoir 
may be easily transmitted to other Pteropus bats species throughout the broad geographic 
distribution of the genus in Southeast Asia, Australia, and coastal Africa.  The risk factors 
leading to seasonal Nipah viral outbreaks in Bangladesh may similarly be exposing 
Bangladeshi settlements to other Pteropus bat viruses.  It is therefore important for public 
health officials to understand the full diversity of viruses present in Pteropus bats, 
especially in Bangladesh, since these bats have often served as sources of devastating 
Nipah viral disease in the region.    
Examining Bangladesh Pteropus bat tissue specimens by cell culture for evidence 
of viral infection may also lead to the identification of novel viral isolates.  Bat viruses 
that cause devastating disease in humans (such as rabies and Nipah viruses) are 
taxonomically classified in much larger ancient viral families (such as the lyssaviruses 
and paramyxoviruses).  Many of the cellular receptors and metabolic pathways used by 
viruses in these ancient viral families were evolutionarily conserved as mammalian 
species diverged.  Therefore, many bat viruses are capable of broadly infecting diverse 
hosts including pigs, horses, and humans.  The identification of novel bat viruses, even if 
they are nonpathogenic to humans, is of public health importance since it may help bat 
virologist further understand what characteristics separate the bat viruses that cause 
human disease from the greater pool of bat viruses that do not.    
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 The Importance of Disease Surveillance in Bats within the Framework of 
Conservation Medicine: 
 
Daszak et al. lamented in 2000 in Science that even though wildlife health, human 
health and ecologic health share common determinants, “[h]istorically, wildlife disease 
has only been considered important when agriculture or human health has immediately 
been threatened” (Daszak et al., 2000, p. 443).  However, the bat-transmitted viruses 
discussed in the preceding sections that cause human diseases considered EIDs were once 
likely confined merely to the bat population before viral spillover led to human infections 
(Daszak et al., 2000; Steele, 1985).  Perhaps some of the morbidity and mortality now 
associated with bat-transmitted EIDs might have been prevented if researchers at the time 
had a more acute awareness of the epidemiology and ecology of bat viruses before human 
disease erupted.  Bat serosurveys are quick and cost-effective methods to explore the 
distribution of viruses maintained in bat reservoirs.  However, until a crisis occurs, 
attention is unfortunately often not focused on such emerging areas of public health 
research (Fauci, 2001; Torres-Velez & Brown, 2004; Weinhold, 2003).  Clearly, public 
health students interested in EID research must familiarize themselves with these 
unconventional concepts and exploratory techniques to prepare to tackle the spread of 
EIDs (Chomel & Osburn, 2006; Daszak et al., 2004; Newman et al., 2005; Torres-Velez 
& Brown, 2004; Weinhold, 2003).   
Focusing on the interaction between the environment, human and non-human 
hosts, and pathogens, the discipline of conservation medicine strives to define the 
unpredictable nature of zoonotic EIDs (Daszak et al., 2004).  Also called ecological 
medicine or medical geology, conservation medicine combines the study of human 
health, animal health, and ecosystem health to describe disease burdens and health 
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 determinants.  Professionals in conservation medicine come from diverse disciplines such 
as microbiology, epidemiology, ecology, wildlife biology, veterinary medicine, and 
clinical medicine.  The discipline is supported by the nonprofit Consortium for 
Conservation Medicine and includes the Bloomberg School of Public Health of The 
Johns Hopkins University, the U.S. Geological Survey National Wildlife Health Center, 
the Harvard Medical School Center for Health and the Global Environment, and the 
Center for Conservation Medicine at the Tufts School of Veterinary Medicine (Weinhold, 
2003).  These scientists advocate for more discussion of EIDs within an ecological and 
social framework within public health schools and institutions (Newman et al., 2005).  
They anticipate an increased demand for veterinarians, ecologists, epidemiologists, and 
modelers to work together in interdisciplinary teams since many of the socio-behavioral 
and environmental risk factors that contribute to EID spread are outside the traditional 
focus of the public health sector (Daszak et al., 2004; Davis et al., 2001; Steele, 1985).   
Researchers using such ecologic approaches to study disease have accurately 
predicted the occurrence of vector-borne and zoonotic EIDs.  Studies like the one 
recently reported by Peterson and colleagues, which characterized habitat similarities in 
Ebola virus outbreaks, demonstrate that ecological approaches to EID study benefit our 
understanding of the epidemiology of EIDs, and are especially useful when little is 
known about the disease reservoir (Peterson et al., 2004).  A timely example, the ongoing 
Rift Valley fever epidemic in Kenya, Tanzania, and Somalia was predicted weeks before 
the first human case was recognized by correlating previous outbreaks with climate and 
precipitation patterns remotely sensed by satellites.  Yet despite this forewarning, the 
 35
 financial and human costs of the outbreak have nevertheless been substantial (Anyamba 
et al., 2006).   
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 Chapter III: Methodology 
 
Study Description: 
The CDC’s Special Pathogens Branch in Atlanta investigated many of the Nipah 
virus outbreaks throughout Southeast Asia detailed in the previous section.  The human 
and bat specimens collected during these investigations were tested by Special Pathogens 
Branch microbiologists for Nipah viral antibody and preserved in -70ºC archives.  In 
addition to the Nipah virus outbreak specimens, human specimens from Southeast Asia 
were also submitted to the Special Pathogens Branch to diagnose individual cases of 
encephalitis of unknown of etiology.   
Nelson Bay (NB) virus and Nipah virus share the same reservoir, bats in the 
genus Pteropus.  Bat species known to carry Nipah viral antibody may also carry NB 
viral antibody.  Human populations with Nipah viral antibody or with environmental and 
behavioral risk factors for exposure to Pteropus bats may have also been exposed to NB 
virus.  It is important for public health officials to be aware of the range of bat viruses 
that may infect humans, the distribution of bat-transmitted viruses in humans and in the 
bat reservoir, and the environmental factors that may affect the prevalence of bat viruses.  
The seroprevalence of NB virus has not been investigated in wildlife or humans.  No 
diagnostic test to detect the presence of NB virus has previously been developed.   
R.W. Compans of Emory University kindly provided a stock of the prototype NB 
virus strain isolated in 1970 from the Nelson Bay area of New South Wales, Australia (G. 
Gard & Compans, 1970).  This strain was used to develop an enzyme-linked 
immunoassay (EIA) to recognize immunoglobulin G (IgG) antibody against NB virus in 
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 humans and bats according to an adaptation of previously established protocol (Ksiazek 
et al., 1999).  A new anti-bat IgG conjugate, prepared in a joint effort between the Special 
Pathogens Branch and Bethyl Laboratories, was used in the NB virus EIA.  Previous bat 
EIAs used a less sensitive and less specific conjugate that recognized the protein A and 
protein G immunoglobulin components generic to all mammals.  In contrast, the anti-bat 
conjugate used in the NB virus EIA specifically recognized a wide variety of bat species 
in both the Megachiropteran and Microchiropteran bat suborders (J.B. Oliver et al., 
Publication in Preparation).  A NB virus serum neutralization assay was also developed 
to confirm the presence of NB virus neutralizing antibody in the EIA positive specimens 
with sufficient volumes available for testing according to an adaptation of a previously 
described protocol (Daniels et al., 2001).  All laboratory work was performed at the 
Special Pathogens Branch.  These laboratory methods are later described in this chapter.   
All human and bat specimens collected during Nipah virus outbreak 
investigations or previously tested for Nipah virus for exploratory purposes were 
retrieved from the Special Pathogens Branch archives and organized into bat and human 
specimen catalogs.  Bat serosurveys are quick and cost-effective methods to explore the 
distribution of viruses maintained in bat reservoirs.  To determine if similarities in the 
seroprevalence patterns of NB virus and Nipah virus exist in the common Pteropus bat 
reservoir of both viruses, the bat sera catalog previously tested for Nipah viral antibody 
by Special Pathogens Branch microbiologists was screened for NB viral antibody using 
the newly developed EIA.  It is unknown if human NB virus infection has occurred in the 
populations with environmental, behavioral, and lifestyle attributes that place them at risk 
for exposure to viruses maintained in Pteropus bat reservoirs.  It is important for public 
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 health officials to determine if NB virus is capable of infecting humans.  Therefore, the 
human specimen catalog previously tested for Nipah viral antibody by Special Pathogens 
Branch microbiologists was also screened for NB viral antibody with the EIA.  The 
Nipah and NB viral antibody prevalences in the human and bat catalogs were then 
compared with respect to the independent variables described in the following section to 
determine if geographic or temporal seroprevalence pattern similarities exist between the 
two viruses.  If seroprevalence pattern similarities are identified, they may be markers of 
unbalanced ecosystems and indicate that larger environmental risk factors are affecting 
the prevalence of bat viruses in Southeast Asia.   Identifying the environmental factors 
that may affect bat viral prevalence may allow public health researchers to target bat-
transmitted disease surveillance strategies to appropriate high-risk environments and 
design intervention strategies to prevent human outbreaks of bat-transmitted disease. 
In a joint investigation by the Special Pathogens Branch and the International 
Centre for Diarrheal Diseases Research (ICDDR) in Dhaka, Bangladesh, spleen and liver 
tissues from 168 bats of five species were collected from February through May of 2004 
during the human Nipah virus outbreak investigation in Bangladesh.  The researchers had 
originally hoped to isolate Nipah virus in cell culture from the bat tissues collected.  To 
examine the ecologic diversity of viruses maintained in bats, the tissues were screened for 
the presence of viruses by cell culture in the Special Pathogens Branch biosafety level-4 
containment lab.  Unknown viral isolates detected were identified via electron 
microscopy performed by C.M. Goldsmith in CDC’s Infectious Disease Pathology 
Branch according to a previously established protocol (Goldsmith et al., 2003).  
Unknown viral isolates were furthermore characterized by immunoflourescent 
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 microscopic examination.  The identification of novel bat viruses, even if they are 
nonpathogenic to humans, is of public health importance since it may help bat virologists 
further understand what characteristics separate the bat viruses that cause human disease 
from the greater pool of bat viruses that do not. 
  
Independent Variables Examined and Tests of Significance: 
Nipah and NB virus seroprevalence patterns within the bat and human catalogs 
were examined with respect to the following characteristics: specimen type, year of 
specimen collection, and country of specimen collection.   Bat seroprevalence was 
additionally examined with respect to bat species.  These characteristics are discussed 
further for the human and bat catalogs in the following two sections.   
For a small cohort of 120 bats collected from Bangladesh in 2004, additional data 
available on the sex, body size, and GPS location of the bat roost was also studied.  The 
following body measurements, which are often used as surrogate measures of age in bats, 
were studied: total body length, weight, foot length, ear length, and forearm length 
(Elangovan et al., 2002).   Mean body measurements were calculated within each bat 
species per sex for the Nipah virus and NB virus seropositive versus seronegative bats 
and examined for a statistically significant difference by independent T-test using SPSS 
15.0 for WindowsTM (© SPSS, Inc., 2001, Chicago IL, www.spss.com).  Statistically 
significant differences in the distribution of Nipah or NB virus antibody between male 
and female bats within each species overall and per bat roost were also examined using 
Pearson’s chi-square analysis or Fisher’s exact test, as appropriate.  Fisher’s exact test is 
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 used instead of Pearson’s chi-square when the expected values of any of the cells in a 
two-by-two contingency table are less than 5 (Hennekens et al., 1987).   
A probability value (P value) associated with the tests was calculated to determine 
if the difference in the distribution was statistically significant.  The P value depends on 
both the magnitude of the difference between the groups and on the sample size.  A P 
value associated with a chi-square test less than or equal to 0.05 means that the observed 
association between bat gender and the presence of Nipah or NB virus antibody would 
not be due to chance in 95 out of 100 similar populations.  In a two-by-two table, the 
odds ratio can also be used to compare whether the odds of an outcome occurring is the 
same within two groups.  The magnitude of the odds ratio varies directly with the 
difference in the distribution of the outcome of interest.  For example, an odds ratio of 
one would imply that the odds of being male versus female were equally as likely in the 
Nipah or NB virus seropositive versus seronegative bats.  An odds ratio greater than one 
implies that there was a greater odds of one gender being seropositive as compared to the 
other bat gender.  The confidence interval around the odds ratio gives the range that 
surrounds the odds ratio at a given percent confidence.  The width of the range of the 
confidence interval indicates the amount of variability in the odds ratio due to the effect 
of sample size (Hennekens et al., 1987).  An odds ratio is statistically significant if at a 
given percent confidence if the confidence interval does not span the null value of one.  
For a given P value of 0.05, the 95 percent confidence interval by definition does not 
include the null value (Hennekens et al., 1987).     
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 Characteristics of the Human Specimen Collection: 
As displayed in Table 2, the human catalog screened for NB viral antibody 
consisted of a total of 1,861 specimens previously tested for Nipah viral antibody by 
Special Pathogens Branch microbiologists.  Seventy-three (73) urine specimens were 
represented in the catalog and all were collected during the 2004 Bangladesh Nipah virus 
outbreak.  The catalog was comprised of 61 cerebral spinal fluid (CSF) specimens.  
Among them, nine were collected from India (two in 2003 and seven in 2004), 49 from 
Bangladesh (41 in the year 2004 and four each in the years 2005 and 2006), and three 
from Indonesia in 2006.  The human catalog additionally contained 1,727 sera specimens 
collected from the years 2001 through 2006 from India, Bangladesh, Thailand, and 
Indonesia.  The human specimens from India in 2001 and from Bangladesh in 2003 and 
2004 were collected as part of the Nipah virus outbreak investigations detailed in the 
preceding chapter.  The specimens from Bangladesh and Thailand in 2004 were collected 
during a retrospective serosurvey of encephalitis among healthcare workers conducted 
throughout Bangladesh and Thailand.  The remaining specimens were submitted to the 
Special Pathogens Branch for Nipah virus testing to investigate clusters of encephalitis 
due to unknown agents. 
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Table 2.  Characteristics of the Human Specimen Catalog 
Urine CSF Serum 
Specimen Group Number Specimen Group Number Specimen Group Number 
Bangladesh, 2004 73 India, 2003 2 India, 2001 26 
Total  73 India, 2004 7 India, 2003 13 
    Bangladesh, 2004 41 India, 2004 7 
    Bangladesh, 2005 4 Bangladesh, 2003 234 
    Bangladesh, 2006 4 Bangladesh, 2004 1,133 
    Indonesia, 2006 3 Bangladesh, 2005 34 
    Total 61 Bangladesh, 2006 23 
        Bangladesh/Thailand, 2004 160 
        Thailand, 2004 77 
        Indonesia, 2006 20 
        Total 1,727 
 
All human patient identifiers were previously stripped from the collection.  The 
CDC human subjects ethics committee Institutional Review Board (IRB) did not require 
further review of the protocol since all specimens were anonymized and did not consider 
this to be human subjects research under 45CFR46.102(f) of the Code of Federal 
Regulations.  The Georgia State University Institutional Review Board determined the 
protocol to be exempt research according to 45CFR46.101(b) (GSU IRB Protocol 
H07178).  Protocol approval was granted by the Georgia State University Internal 
Biosafety Committee (Protocol Approval B07004).  
 
Characteristics of the Bat Sera Collection: 
The catalog of bat specimens screened for antibody evidence of NB virus 
consisted of 2,323 sera specimens.  All bat specimens had previously been tested for 
Nipah viral antibody by Special Pathogens Branch microbiologists.  The bat sera 
specimens were collected in the years 1993 through 2006 from Bangladesh, Thailand, 
Cambodia and Singapore or from wild-caught bats from locations throughout Southeast 
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 Asia acquired by bat conservation groups.  Detailed specimen histories were lacking for 
the specimens submitted from the bat conservation groups, and so it was unknown which 
of the specimens from these groups were collected from wild-caught bats, which 
specimens were collected from bats raised in captivity, or if specimens from the same bat 
were tested multiple times.   
Many of the bat specimens screened were originally collected as ecological 
serosurveys for Nipah virus in bats.  The bat specimens from Bangladesh in 2003 and 
2004 were collected as part of the Nipah virus human outbreak investigations detailed in 
the previous chapter.  Twenty-seven species, many of which are rare or endangered, were 
represented in the catalog.  Table 3 shows the distribution of the bat specimens examined 
by specimen group.   
Table 3.  Characteristics of the Bat Sera Catalog 
Specimen Group Number 
Bat Conservancy Groups, 1993-2006 1,569 
Cambodia, 2000 244 
Cambodia, 2001 109 
Singapore, 2000 3 
Thailand, 2002 175 
Bangladesh, 2003 56 
Bangladesh, 2004 168 
Total 2,323 
 
Table 4 on the following page displays the distribution of the bat specimens 
screened by species, location(s) of specimen collection, and gives the species taxonomic 
classification.   
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Laboratory Methods: 
Nelson Bay (NB) Virus and Unknown Virus Isolation Techniques: 
 
Ten ml of a 10-2 dilution in Hanks Balanced Salt Solution (HBSS) of NB virus 
(prototype strain isolated from the Nelson Bay area of New South Wales, Australia 
provided by R.W. Compans of Emory University) was inoculated into 850 cm2 roller 
bottles of confluent Vero E6 cells and incubated at 37ºC for 1 hour.  Rollers were then re-
fed with 150 ml of Eagle’s Minimum Essential Medium (EMEM) with 2% fetal calf 
serum and incubated at 37ºC.  Rollers were examined daily for development of 
cytopathic effects (CPE).  Successful infection was established by indirect 
immunofluorescence assay (IFA) examination of the slides using mouse anti-NB virus 
hyperimmune ascitic fluid (HMAF) as a primary antibody (1:100 dilution).  Slides were 
incubated with 25 µl of the HMAF solution for 30 min at 37ºC in a humidified incubator, 
washed with 0.01M PBS at pH 7.2, and allowed to dry.  25 µl of a florescent-labeled anti-
mouse antibody commercially available from Cappel (rehydrated per manufacturer’s 
instructions and used at a 1:40 dilution) was then applied to the slides.  Slides were again 
incubated for 30 min at 37ºC, washed with 0.01M PBS at pH7.2, counterstained with 
eriochrome black-T, and allowed to dry.  Slides were examined using florescent 
microscopy. 
To screen for virus in the spleen and liver tissues from the 168 bats collected in 
2004 from Bangladesh, the tissues were ground using a mortar and pestle in HBSS and 
alundum in the biosafety level-4 containment lab.  The resulting suspension was 
centrifuged and 100 µl of this supernatant was used to inoculate confluent Vero E6 cells 
 46
 in 25 cm2 flasks and incubated at 37ºC for 1 hr. After incubation, flasks were re-fed with 
EMEM with 2% fetal calf serum and incubated at 37ºC.  When CPE developed, cells 
were scraped from the rollers, fixed to slides, inactivated with 2×106 rads of gamma 
irradiation (Co-60 source), and examined by IFA.  
 
Electron Microscopy of Unknown Virus Isolates: 
 
Electron microscopy identification of unknown viral isolates detected in the 
tissues from the 168 bats collected in 2004 from Bangladesh was performed by C.M. 
Goldsmith of the Infectious Disease Pathology Branch, CDC according to a previously 
established protocol (Goldsmith et al., 2003).  Essentially, supernatant from infected 
Vero E6 flasks displaying CPE were fixed in 2.5% gluteraldehyde (1:1) for 5 hrs.  The 
fixative was decanted and replaced with sodium phosphate buffer, pH 7.2 and inactivated 
by gamma irradiation (2×106 rads using a Co-60 source).  The resulting specimens were 
embedded in epoxy and thin sections were stained with uranyl acetate and lead citrate for 
visualization.   
 
Nelson Bay (NB) Virus Mouse Hyperimmune Ascitic Fluid (HMAF) Development: 
 
Mouse antibodies to NB virus were produced by P.E. Rollin of the Special 
Pathogens Branch according to a previously detailed protocol (Brandt et al., 1967).  Ten 
pathogen-free female mice were immunized by two intraperitoneal inoculations of a 0.3% 
Beta-propiolactone inactivated 10% suckling mice brain suspension of prototype NB 
virus in Freund’s complete adjuvant two weeks apart.  On day 28, the mice were injected 
with a Sarcoma TG-180 cell suspension by the intraperitoneal route.  Mice were then 
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 tapped on day 30.  The resulting NB virus HMAF was pooled, inactivated by gamma 
irradiation (2×106 rads using a Co-60 source), and tested for reactivity by checkerboard 
cross-titration EIA.  All animal procedures were performed in accordance with CDC’s 
Interagency Animal Care and Use Committee approved protocols in the biosafety level-4 
laboratory.   
 
Indirect Nelson Bay (NB) Virus IgG EIA Development: 
 
R.W. Compans of Emory University kindly provided a stock of the prototype NB 
virus strain isolated in 1970 from the Nelson Bay area of New South Wales, Australia (G. 
Gard & Compans, 1970).  This strain was used to develop an enzyme-linked 
immunoassay (EIA) to recognize immunoglobulin G (IgG) antibody against NB virus in 
humans and bats according to an adaptation of previously established protocol (Ksiazek 
et al., 1999).  Briefly, NB virus antigen (prototype strain) was extracted from infected 
Vero E6 cells using detergent, inactivated by gamma irradiation (2×106 rads using a Co-
60 source), and sonnicated.  Antigen from uninfected Vero E6 cells was similarly 
prepared and used as a negative control against nonspecific sera binding.  100 µl per well 
of the antigens was absorbed to 96-well plates (BD Falcon Cat No. 353910) at a dilution 
of 1:1000 in 0.01M PBS, pH 7.2 as previously determined by checkerboard cross-
titration with NB virus positive hyperimmune mouse ascitic fluid (HMAF) and allowed 
to incubate overnight at 4ºC.  The plates were then washed three times with 200 µl of a 
0.01M PBS and 0.1% Tween-20 wash buffer solution at pH 7.2 and 100 µl per well of 
the unknown human or bat sera was applied to the plates in 4-fold serial dilutions starting 
with an initial dilution of 1:100.  All sera was also inactivated by gamma cell irradiation 
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 (2×106 rads with a Co-60 source) and diluted in serum diluent (0.01M PBS pH 7.4, 0.5% 
skim milk, and 0.1% Tween-20).  The sera was allowed to bind to the antigen for 1 hour 
at 37ºC in a humidified incubator,  plates were then washed three times with 200 µl of 
wash buffer solution, and 100 µl per well of the appropriate commercially available 
conjugate was added.  Anti-bat IgG conjugate (H+L) from Bethyl Laboratories 
(rehydrated in 1 ml of 50:50 solution of glycerol:water) was applied at a 1:2000 dilution 
in serum diluent for the bat sera screening or anti-human IgG (H+L) from Accurate at a 
1:4000 dilution in serum diluent was applied for the human sera screening.  Plates were 
again incubated for 1 hr at 37ºC, washed, and 100 µl per well of ABTS substrate solution 
commercially available from Kirkgard and Perry Laboratories and prepared per 
manufacturer’s instructions was applied.  After a final 30 min incubation at 37ºC, plates 
were read at 405 nm and 495 nm absorbance.  A positive reaction was defined as a titer 
greater than or equal to 400 and a sum optical density (OD) greater than or equal to a 
three-fold standard deviation increase from the mean sum OD of the negative sera after 
subtracting nonspecific sera binding to the negative control antigen.   
 
Nelson Bay (NB) Virus Serum Neutralization Assays: 
Considered the gold standard for the detection of neutralizing antibodies to a virus 
in question, serum neutralization assays were performed on the NB virus EIA positive 
specimens with sufficient volumes available.  Serum samples were heated for 30 min at 
56°C and then were titrated with five dilutions (1:10; 1:40, 1:160, 1:640, and 1:2560) in a 
24-well culture plate. An equal volume of NB virus (at 100 times the 50% tissue culture 
infective dose (TCID50) in 100 µl) was added to all sera, and the plate was incubated for 
1 hr at 37°C. Vero E6 cells (5 ×105 cells/ml in EMEM with 5% FBS) were added to all 
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 wells, and the plates were incubated at 37°C for 7 days in a CO2 chamber. All wells were 
examined daily for characteristic cytopathic effects (CPE) showing large syncytia under a 
microscope in each well. The number of virus-positive wells was confirmed after fixation 
with two successive changes of 5% glacial acetic acid in absolute ethanol for 30 min 
each.  Plates were gamma irradiated at 2×106 rads using a Co-60 source and then stained 
with 1 ml of crystal violet stain for 15 min, washed with deionized water, and plaques 
were counted.  Toxicity of the sera for Vero cells was observed on uninfected cells in the 
presence of 1:10 serum dilution.  Normal mouse and NB virus HMAF were used as 
positive and negative serum controls, respectively.  The neutralization titer of each 
sample was defined as the last serum dilution in which at least half of the monolayer was 
intact (TCID50).   
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 Chapter IV: Results 
 
Nipah Virus Seroprevalence Patterns in the Human Specimen Collection: 
 
As was determined by the previous Nipah virus serologic testing conducted by the 
Special Pathogens Branch, none of the 73 human urine specimens collected during the 
2004 Bangladesh Nipah virus outbreak were Nipah virus seropositive.  Of the 61 CSF 
specimens in the human specimen catalog, only one specimen collected during the 2004 
Bangladesh Nipah virus outbreak investigation was Nipah virus antibody positive.      
Out of the 1,727 human serum specimens in the collection screened for NB viral 
antibody, only 46 were Nipah virus antibody positive (2.7%).  Thirty-eight (38) of the 46 
Nipah virus antibody positive human serum specimens were obtained from the Nipah 
virus outbreak investigations conducted in Bangladesh in the years 2003, 2004, and 2005.  
This data is displayed in Table 5.  Aside from the Bangladesh outbreak specimens, the 
only other Nipah virus antibody positive human sera in the catalog was collected from the 
2001 Nipah virus outbreak in India and from the retrospective serosurvey of encephalitis 
among healthcare workers conducted throughout Bangladesh and Thailand in 2004.  
Seven of the 26 sera (26.9%) collected during the 2001 Indian Nipah virus outbreak were 
antibody positive, as was one specimen of  the 160 (0.6%) from the 2004 healthcare 
worker serosurvey in Bangladesh and Thailand. 
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Table 5.  Distribution of the Human Sera Screened by Group. 
Group 
Number of 
Sera in 
Group 
Percent of 
the Total 
Sera in 
Group 
Number of 
Seropositive in 
Group  
Percent of 
Group 
Nipah 
Positive 
Percent of the 
Total 
Seropositive in 
Group 
India, 2001 26 1.5% 7 26.9% 15.2% 
India, 2003 13 0.8% - - - 
India, 2004 7 0.4% - - - 
Bangladesh, 2003 234 13.5% 9 3.8% 19.6% 
Bangladesh, 2004 1133 65.6% 25 2.2% 54.3% 
Bangladesh, 2005 34 2.0% 4 11.8% 8.7% 
Bangladesh, 2006 23 1.3% - - - 
Thailand, 2004 77 4.5% - - - 
Bangladesh/ 
Thailand, 2004 160 9.3% 1 0.6% 2.2% 
Indonesia, 2006 20 1.2% - - - 
Total Percent 1,727 100% 46 2.7% 100% 
 
 
Nipah Virus Seroprevalence Patterns in the Bat Sera Collection: 
Overall, 200 (8.6%) of the bat serum specimens were Nipah virus antibody 
positive, as determined by previous laboratory testing by the Special Pathogens Branch.  
Table 6 gives the distribution of the bat specimens screened by specimen group.  As is 
highlighted in yellow in Table 8, note that even though the 168 specimens in the 2004 
Bangladesh bat cohort made up only 7.2% of the entire bat catalog of 2,323 specimens, 
24.5% of the 200 Nipah virus antibody positive bat specimens belonged to the cohort.  
The 2004 Bangladesh bat specimens were collected as part of the ecological serosurveys 
for Nipah virus in bats conducted during the human Nipah virus outbreak investigation in 
Bangladesh in 2004 (Carroll et al., Publication in Preparation).  Of note, the virus 
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 isolation screening results reported by this research was conducted on the spleen and liver 
tissues from the 168 bats in 2004 Bangladesh cohort. 
 
Table 6.  Distribution of the Bat Sera Screened by Specimen Group. 
Group 
Number of 
Sera in 
Group 
Percent of the 
Total Sera in 
Group 
Number of 
Nipah Virus 
Seropositive 
in Group  
Percent of 
Group 
Nipah 
Positive 
Percent of 
the Total 
Nipah 
Virus 
Seropositive 
in Group 
Bat Conservancy 
Groups, 1993-2006 1,569 67.5% 143 9.1% 71.5% 
Cambodia, 2000 244 10.5% 5 2.0% 2.5% 
Cambodia, 2001 109 4.7% - - - 
Singapore, 2000 3 0.1% - - - 
Thailand, 2002 175 7.5% 1 0.6% 0.5% 
Bangladesh, 2003 56 2.4% 2 3.6% 1.0% 
Bangladesh, 2004 168 7.2% 49 29.2% 24.5% 
Total Percent 2,323 100% 200 8.6% 100% 
 
As displayed in Table 8, the bulk of the 2,323 specimens screened (67.5%) were 
collected from bat conservation groups and 143 (9.1%) of these were Nipah virus 
antibody positive.  Since detailed specimen histories from the bat conservation groups 
were lacking, it was unknown if these Nipah virus antibody positive bats were captured 
in the wild, if they were raised in captivity, or if multiple specimens from the same 
animal were screened.  Of the 353 sera from Cambodia (collected in 2000 and 2001), 
1.4% were positive for Nipah viral antibody.  Of note, the Cambodian bat specimens 
screened were obtained from animals later prepared and served as a local delicacy in 
restaurants in Phnom Penh (Olson et al., 2002).  None of the three specimens from 
Singapore were positive and only one of the 175 specimens (0.6%) collected from 
Thailand was Nipah virus antibody positive.   
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 The two remaining Nipah virus antibody positive specimens were collected 
during the bat serosurveys conducted by the investigators of the 2003 Bangladesh Nipah 
virus outbreak.  Of the 56 bat specimens in the panel from Meherpur and Naogaon, 
Bangladesh collected in 2003 by Hsu et al., two Pteropus giganteus species bats from 
Naogaon (3.6%) were Nipah virus seropositive (Hsu et al., 2004).  In comparison, the 
2004 Bangladesh Nipah virus outbreak investigation in the town of Goalando in the 
Rajbari district revealed that 48 of the 109 (44.0%) P. giganteus bats collected were 
Nipah virus antibody positive, as was one of the 30 (3.3%) Rousettus leschenaulti bats 
collected (Carroll et al., Publication in Preparation).  Including all five bat species 
collected during the 2004 Bangladesh outbreak, 29.2% of the 168 total bats were Nipah 
virus antibody positive (Carroll et al., Publication in Preparation).   
All 200 Nipah virus antibody positive bat specimens were collected from Old 
World fruit bats in the Pteropodinae subfamily.  Of the 1,889 Pteropodinae bats screened, 
10.6% were Nipah virus antibody positive.  Moreover, 199 out of the 200 Nipah virus 
antibody positive bats belonged to the Pteropus genus while the remaining Nipah virus 
antibody positive specimen was from a Rousettus leschenaulti bat.  A pie chart 
distribution by species of the 200 Nipah virus antibody positive bats is displayed in 
Figure 5.  Nipah viral antibody was present in the following seven bat species in the bat 
sera catalog: P. giganteus, P. vampyrus, P. rodricensis, P. pumilus, P. lylei, P. 
hypomelanus, and R. lechenaulti.  Sixty-seven percent (67%) of the Nipah virus antibody 
positive bats were from the P. giganteus and P. vampyrus species, though these two 
species made up only 30.8% of the entire collection.   
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 Distrubution of the 200 Nipah Virus Antibody 
Positive Bats by Species
Pteropus 
rodricensis
17.5%
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7.5%
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3.0%
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leschenaulti
0.5%
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41.5%
 
Figure 5.  Distribution of the Nipah Virus Antibody Positive Bat 
Specimens by Species. 
   
 
Nelson Bay (NB) Virus EIA Serology Results:  
None of the 1,861 human specimens screened were positive for NB virus.  
Fourteen (14) NB virus antibody positive bats were detected out of 2,323 specimens 
screened (0.6%).  As discussed in the Laboratory Methods section, the NB virus sum OD 
cut off values for the bat and human assays were calculated based on a three-fold 
standard deviation increase from the mean sum OD of the negative sera after subtracting 
nonspecific sera binding to the negative control antigen.  The calculated NB virus sum 
OD cutoff values were 0.85 for the bat sera screening and 1.30 for the human sera 
screening.  The bat and human sera sum OD values were normally distributed.   The sum 
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 OD frequency distributions are displayed as histograms in Figures 6 and 7 for the human 
and bat screening, respectively.  
 
 
Figure 6.  Human NB Virus EIA Sum OD Frequency 
Distribution Histogram.  The frequency distribution of the sum 
OD values generated by the NB virus EIA of the human 
specimens.   
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Figure 7.  Bat NB Virus EIA Sum OD Frequency Distribution 
Histogram.  The frequency distribution of the sum OD values 
generated by the NB virus EIA of the bat specimens. 
 
 
Nelson Bay (NB) Virus Serum Neutralization Assay Results: 
A sufficient quantity of sera from nine of the 14 NB virus seropositive bat 
specimens was available for serum neutralization testing.  All specimens tested by serum 
neutralization were positive for the presence of neutralizing antibodies to NB virus. 
Seven of the nine specimens had neutralizing antibody titers at a dilution of 1:2,560.  One 
of the remaining two sera specimens tittered to a dilution of 1:640 and the other specimen 
had neutralizing antibody only to a dilution of 1:160.  The antibody titer dilution of the 
serum specimen corresponds to the concentration of neutralizing antibody present in the 
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 sample: the greater the antibody titer dilution, the more antibody capable of neutralizing 
the NB virus present in the sample. 
 
Nelson Bay (NB) Virus Seroprevalence Patterns in the Specimen Collections: 
Since no human specimens were NB virus antibody positive, no seroprevalence 
patterns were detected in the human specimen catalog.  Therefore, the human catalog 
could not be further examined for pattern similarities in the seroprevalences of Nipah and 
NB viruses.  Of the 14 NB virus antibody positive bat specimens detected, ten were 
collected from R. leschenaulti species bats, one was collected from a Rousettus bat of 
unknown species, two were collected from P. giganteus bats, and the final positive 
specimen was collected from a P. vampyrus species bat.  The 13 NB virus seropositive 
Rousettus and P. giganteus bats detected in the screening belonged to the cohort of 168 
bat specimens collected during the 2004 Bangladesh human Nipah virus outbreak 
investigation; the one remaining NB virus seropositive P. vampyrus specimen was 
collected in 2000 from an unknown location by a bat conservation group.  Although it 
cannot be confirmed, it is likely that the bat conservation group obtained this specimen 
from a bat captured in Malaysia.   
 
Nipah and Nelson Bay (NB) Virus Seroprevalence Pattern Similarities in the Bat 
Sera Collection: 
 
As previously displayed in the pie chart in Figure 5, seven of the 27 bat species 
represented in the collection were Nipah virus seropositive.  These seven species were 
previously identified in the literature as Nipah viral antibody carriers and all were 
taxonomically classified in the Pteropodinae subfamily within the Megachiropteran 
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 suborder.  Nelson Bay (NB) viral antibody was successfully detected in three of the seven 
Nipah seropositive bat species (P. giganteus, P. vampyrus, and R. lechenaulti).  Table 7 
on the following page presents the distribution of the Nipah and NB virus serology 
positive specimens by species.     
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As Table 7 displayed, 10 of the 30 (33.3%) total R. leschenaulti specimens 
screened were NB virus antibody positive.  In contrast, the Nipah virus seroprevalence in 
the 30 R. leschenaulti bats was 3.3%.  In the other two bat species found to carry NB 
viral antibody, the NB viral seroprevalence was merely 0.7% of  the 274 P. giganteus 
screened and 0.2% of the 442 P. vampyrus screened.  In comparison, the Nipah viral 
antibody prevalence in the P. giganteus bats screened was 30.3% and 11.5% in the P. 
vampyrus bats.       
Out of the 14 total NB virus seropositive bats detected in the screening, the 13 NB 
virus seropositive Rousettus and P. giganteus species bats belonged to the cohort of 168 
bat specimens collected during the 2004 Bangladesh human Nipah virus outbreak 
investigation.  The only Rousettus specimens in the catalog screened were collected 
during the 2004 Bangladesh Nipah virus human outbreak investigation from a single bat 
roost near the location of the human Nipah virus cases.  Bat roost GPS locations, gender, 
and bat body measurements were recorded in the field for 120 of the 168 bats in the 
Bangladesh 2004 cohort.  Further statistical characterization of the Nipah and NB virus 
antibody positive R. leschenaulti and P. giganteus bats from the Bangladesh 2004 cohort 
was possible using this data.  
Of the 109 P. giganteus bats collected in Bangladesh in 2004, only two (1.8%) 
were NB virus antibody positive (one male and one female).  Both of these bats, 
however, also tested positive for Nipah viral antibody.  A R. leschenaulti female and a 
Rousettus bat of unknown species and unknown sex additionally tested positive for both 
Nipah and NB viral antibody in the Bangladesh 2004 cohort.  Therefore, four of the 14 
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 (28.6%) total NB virus seropositive bats identified in this screening were also 
simultaneously positive for Nipah viral antibody.   
  
Nipah and Nelson Bay (NB) Virus Seroprevalence Pattern Similarities with Respect 
to Bat Gender: 
 
As displayed in Table 8, seven of the 14 (50.0%) R. leschenaulti females collected 
in the 2004 Bangladesh human Nipah virus outbreak investigation were positive for NB 
viral antibody, as were three of the 16 (18.8%) males. Therefore, a greater percentage of 
R. leschenaulti females as compared to males were NB virus antibody positive, but due to 
the small sample size, this difference in the distribution of seroprevalence by sex was not 
statistically significant (P=0.122) by Fisher’s exact test.  In terms of the odds ratio, there 
was a 4.3 times greater odds of being female than male among the R. leschenaulti 
seropositive bats, but the odds of being female were not statistically significant (95% 
confidence interval=0.8-22.2). 
Table 8.   NB Virus Seroprevalence by Gender in the 
Rousettus leschenaulti Bats.  The bats were collected near 
the 2004 human Nipah virus outbreak in Bangladesh from 
a single bat roost.  Differences in the distribution by 
gender were not statistically significant. 
Species: Rousettus leschenaulti; n=30 
  
Number NB 
Virus 
Seropositive
Number NB 
Virus 
Seronegative Total 
Number Female 7 7 14 
Number Male 3 13 16 
Total 10 20 30 
P Value 0.122     
Odds Ratio 4.3     
95% Confidence 
Interval 0.8, 22.2     
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 Conversely, Nipah virus antibody was more likely to be found in the P. giganteus 
males than the females, and this distribution difference was statistically significant 
(P=0.023) by Person’s chi-square analysis.  Sixty percent (60%) of the 42 P. giganteus 
males were antibody positive for Nipah virus whereas only 40% of the 48 P. giganteus 
females were positive, as displayed in Table 9.  Explained in terms of the odds ratio, 
there was a 2.7 times greater odds of the Nipah virus seropositive P. giganteus bats being 
male as opposed to female and the odds were statistically significant based on the 95% 
confidence interval of 1.1-6.3.   
Table 9.   Nipah Virus Seroprevalence by Gender in the 
Pteropus giganteus Bats.  The bats were collected during 
the 2004 human Nipah virus outbreak investigation in 
Bangladesh.  Differences in the distribution by gender 
were statistically significant. 
Species: Pteropus giganteus; n=90 
  
Number 
Nipah Virus 
Seropositive 
Number 
Nipah Virus 
Seronegative Total 
Number Male 24 18 42 
Number Female 16 32 48 
Total 40 50 90 
P Value 0.023     
Odds Ratio 2.7     
95% Confidence 
Interval
1.1, 6.3 
    
 
 
 Nipah and Nelson Bay (NB) Virus Seroprevalence Pattern Similarities with Respect 
to Mean Bat Body Measurements: 
 
 Table 10 gives the mean total body lengths, foot lengths, ear lengths, forearm 
lengths, and weights of the R. leschenaulti and P. giganteus bats in the 2004 Bangladesh 
bat cohort.   
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 Table 10.  R. leschenaulti and P. giganteus Mean Body Measurements.  
The mean total body lengths, foot lengths, ear lengths, forearm lengths, 
and weights of the Rousettus leschenaulti and Pteropus giganteus bats 
collected during the 2004 human Nipah virus outbreak investigation in 
Bangladesh. 
  Species 
  
Rousettus 
leschenaulti 
Pteropus 
giganteus 
  Males Females Males Females
Number Collected 16 14 42 48 
Mean Total Body Length (mm) 120.9 119.0 236.1 237.6 
Mean Foot Length (mm) 20.0 21.1 43.9 44.3 
Mean Ear Length (mm) 20.3 20.3 36.4 37.2 
Mean Forearm Length (mm) 84.6 82.8 170.8 167.2 
Mean Weight (g) 107.6 96.2 678.6 621.9 
 
No statistically significant difference in mean foot length or total body length was 
detected between the Nipah and NB virus antibody positive versus negative P. giganteus 
and R. leschenaulti bats per sex by independent T-test.  There was, however, a 
statistically significant (at the P≤0.10 level) greater mean weight (P=0.079) and mean ear 
length (P=0.061) in the Nipah virus seropositive P. giganteus males as compared to the 
seronegative males.  The 95 percent confidence interval around the difference in mean 
value was also calculated.  This data is shown in Table 11.  Note that all the mean body 
measurements were greater in the Nipah virus seropositve P. giganteus males compared 
to the seronegative males, although only the difference in mean ear length and mean 
weight was statistically significant. 
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Table 11.  Independent T-test of Body Measurements in Nipah Virus Antibody Positive P. giganteus 
Males.  Statistically significant values are marked with asterisks. 
Pteropus giganteus Males: n=42 
  
Nipah 
Virus 
Antibody 
Positive 
Nipah 
Virus 
Antibody 
Negative 
P 
Value 
 
Difference 
in Means 
95% 
Confidence 
Interval 
Mean Forearm Length (mm) 173.6 166.6 0.162 7.0 -2.9, 17.0 
Mean Weight (g) 715.5 629.4 0.079* 86.0  -10.3, 182.3* 
Mean Total Body Length (mm) 240.2 230.6 0.242 9.6  -6.8, 26.1 
Mean Ear Length (mm) 37.5 34.9 0.061* 2.6  -0.1, 5.3 
Mean Foot Length (mm) 44.4 43.2 0.628 1.3  -3.9, 6.4 
 
Similarly, there was a statistically significant (at the P≤0.10 level) greater mean 
forearm length among the NB virus antibody positive R. leschenaulti females versus the 
seronegative females by independent T-test, as displayed in Table 16 below.  Again, note 
that all the mean body measurements were greater for the NB virus seropositive R. 
leschenaulti females than the seronegative females, although only the difference in mean 
forearm length was statistically significant at the P≤0.10 level.   
Table 12.  Independent T-test of Body Measurements in NB Virus Antibody Positive R. leschenaulti 
Females.  Statistically significant values (at the P≤0.10 level) are marked with asterisks. 
Rousettus leschenaulti Females: n=14 
  
NB Virus 
Antibody 
Positive 
NB Virus 
Antibody 
Negative 
P 
Value 
Difference 
in Means 
95% 
Confidence 
Interval 
Mean Forearm Length (mm) 84.1 81.4 0.067* 2.7 -5.7, 0.2  
Mean Weight (g) 98.6 93.9 0.210 4.7  -12.5, 3.0 
Mean Total Body Length (mm) 120.7 117.3 0.448 3.4 -12.9, 6.1 
Mean Ear Length (mm) 20.9 19.7 0.351 1.2  -3.7, 1.4 
Mean Foot Length (mm) 21.3 21.0 0.856 0.3  -3.6, 3.1 
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 Nipah and Nelson Bay (NB) Virus Seroprevalence Pattern with Respect to Bat Roost 
Location:  
 
The bats specimens obtained during the 2004 Bangladesh human Nipah virus 
outbreak investigation were collected from bats captured from 11 bat roosts found near 
the human settlements that experienced cases of Nipah virus infection.  Each roost 
sampled contained approximately 100-200 individuals and roosts were located 
approximately 0.5 to 30 km from the areas where human cases were reported (Carroll et 
al., Publication in Preparation).  The distribution of NB virus and Nipah virus 
seropositive bats by roost GPS location and species is shown in Table 13.  Roosts 1, 2, 
and 11 contained both NB virus and Nipah virus seropositive individuals.  All 11 roosts 
were Nipah virus antibody positive except for roosts 5 and 9.  All 30 R. leschenaulti 
species bats were collected from a single bat roost (roost 1), ten of which (33.3%) were 
NB virus antibody positive.  A map showing the locations of the roosts is presented in 
Figure 8.  As indicated by the scale on the roost map, the greatest distance “as the bat 
flies” between any two roosts was approximately 76 km. 
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Table 13.  Nipah and NB virus Seroprevalence by Bat Roost.  Seroprevalence 
distributed by bat roost and species among the bats in the Bangladesh 2004 
cohort.    Bat roosts were located 0.5 to 30 km from the areas where human 
Nipah virus cases were reported.   Note that roosts 1, 2, and 11 are NB and 
Nipah virus seropositive while all other roosts except 5 and 9 are seropositive 
for Nipah virus.  There was not a statistically significant difference in the 
distribution of Nipah or NB virus positive males versus females within each 
roost per species (data not shown). 
Bat 
Roost Species 
Number 
Collected
Percent  
Nipah 
Virus 
Antibody 
Positive 
Percent  
NB 
Virus 
Antibody 
Positive 
1 Rousettus leschenaulti 30 3.3% 33.3% 
 Pteropus giganteus 1 - - 
2 Pteropus giganteus 15 33.3% 6.7% 
3 Pteropus giganteus 6 66.7% - 
4 Pteropus giganteus 17 52.9% - 
5 Pteropus giganteus 1 - - 
6 Pteropus giganteus 12 50.0% - 
7 Pteropus giganteus 9 33.3% - 
8 Pteropus giganteus 14 50.0% - 
9 Cynopterus sphinx 2 - - 
 Megaderma species unknown 1 - - 
 
Hipposideros species 
unknown 1 - - 
 Eonycteris spelaea 1 - - 
 Cynopterus species unknown 1 - - 
10 Pteropus giganteus 4 25.0% - 
11 Pteropus giganteus 11 45.4% 9.1% 
  Total 126 32.5% 9.5% 
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 Figure 8.  Map of Bat Roost Locations.  
Map B (below) is an enlargement of the area 
in Central Bangladesh near Faridpur shown 
in red in Map A (at left).  Map B depicts the 
locations of the 11 bat roosts where the 2004 
Bangladesh cohort of bats were collected.  
The scale of the map is in the lower left 
corner.  Roost locations are marked with red 
crosses.  Nipah virus seropositive roosts 
(roosts 1-4, 6-8, 10-11) are indicated in 
white. Nipah and NB virus seropositive 
roosts (roosts 1, 2, and 11) are indicated in 
yellow.  Map A is available at 
www.infoplease.com.  Map B was created 
using Google Earth.  
A
 
B
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 Virus Isolation Results: 
Overall, 29.3% of the 168 bats from five species collected during the 2004 
Bangladesh human Nipah virus outbreak investigation showed antibody evidence of 
Nipah virus infection by serology, but Nipah virus was not successfully isolated from any 
of the bat tissues (Carroll et al., Publication in Preparation).  The virus isolation attempts 
made on the 168 bat spleens collected from the bats in the 2004 Bangladesh cohort 
yielded two unknown syncytia-forming (cell fusing) virus isolates.  The two unknown 
isolates were obtained from the spleens of two P. giganteus bats: one from a male bat 
from roost 11 and the other from a female from roost 7 (See Table 13 and Figure 8).  
Roost 11 contained bats positive for both Nipah and NB viruses while roost 7 contained 
only Nipah virus antibody positive individuals. 
Although the unknown isolates were initially believed to be paramyxoviruses, 
such as Nipah or Hendra viruses, electron microscopy by C.M. Goldsmith in the 
Infectious Disease Pathology Branch, CDC indicated that the virus isolates were 
orthoreoviruses.   Similar to NB virus, the isolates produced unique fusogenic cytopathic 
effects in cell culture.  However, the unknown isolates did not react with NB viral 
antibody by indirect immunoflourescent microscopic examination.   
The unknown isolates displayed the growth pattern and the ultrastructural 
morphology of bat orthoreoviruses (which include NB virus, Pulau virus, and purportedly 
Broome virus).  However, unlike the previously characterized bat orthoreoviruses (NB 
virus and Pulau virus), the isolates did not cross-react with NB viral antibody (Pritchard 
et al., 2006).  The isolates are therefore distinct from Pulau virus and NB virus, the only 
other characterized bat orthoreoviruses, identified previously in 2005 and 1970, 
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 respectively.  Serologic assays developed from antigen extracts of the two unknown viral 
isolates did not detect antibody capable of recognizing the unknown viruses in the 
Bangladesh bat or Bangladesh human sera collections.   
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 Chapter V: Discussion and Conclusion 
 
The Implications of the Virus Isolation Results: 
  In a timely bat virology review article published March 2007 in Clinical 
Infectious Diseases, Halpin et al. presented the following figure showing the origins of 
the three previously identified bat orthoreoviruses (NB virus, Pulau virus, and Broome 
virus) along with the geographic distribution of Pteropus bats in Southeast Asia and 
Australia (Halpin et al., 2007).  Broome virus, which has not yet been characterized in the 
literature, was purportedly isolated from a bat in Australia, as was NB virus, while Pulau 
virus was isolated from a bat in Malaysia.   
 
 
Figure 9.  Map of the Bat Orthoreovirus Isolates.  The geographic origins of 
the previously reported bat orthoreoviruses superimposed over the distribution 
of the Pteropus bat genus (pink shading)  (Halpin et al., 2007, Fig 2, p. 714, 
Clinical Infectious Diseases).   
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This research reported the identification of two previously unknown bat 
orthoreoviruses obtained from the spleen tissues of the 168 bats in the 2004 Bangladesh 
cohort.  The results of this research support hypothesis (1) which stated that culturing the 
bat tissues collected during the 2004 Bangladesh Nipah virus outbreak will result in the 
identification of novel viral agents.  Therefore, Figure 9 could be updated with a fourth 
marker indicating the existence of both NB virus and a NB-like orthoreovirus in 
Bangladesh in addition to the three Australian and Malaysian bat orthoreoviruses the 
figure illustrates.  Such an update to Figure 9 would further emphasize the broad 
distribution of viruses maintained in Pteropus bat reservoirs.   
Future virus isolation studies will likely reveal the discovery of other bat 
orthoreoviruses in addition to the two new NB-like strains reported here.  Bat viruses 
such as rabies, SARS, and Nipah viruses have often caused devastating disease in 
humans.  Bat viruses from ancient viral families often have the ability to infect diverse 
groups of mammalian species since many use cellular receptors and metabolic pathways 
that were evolutionarily conserved in mammals as species diverged.  The identification of 
novel bat viruses, even if they are nonpathogenic to humans, is of public health 
importance since it may help bat virologists further understand what characteristics 
separate the bat viruses that cause human disease from the greater pool of bat viruses that 
do not.  Identifying the characteristics that enable bat viruses to cause human disease may 
allow public health officials to formulate intervention strategies to prevent or mitigate 
future outbreaks of bat viral disease. 
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 Interpretation of the Nipah Virus Seroprevalence in the Human Specimen Catalog: 
The human catalog screened consisted of 1,861 CSF, urine and serum specimens 
collected from India, Bangladesh, Thailand, and Indonesia in the years 2001 through 
2006.  The Special Pathogens Branch previously tested all specimens for Nipah viral 
antibody.  None of the 73 urine specimens were positive for Nipah viral antibody.  Of the 
61 CSF specimens tested, only one specimen collected during the Bangladesh 2004 
Nipah virus outbreak was Nipah virus antibody positive.  Forty-six (46) of the 1,727 
human serum specimens were Nipah virus antibody positive.  As was displayed in Table 
5, 82.6% of the 46  total Nipah virus antibody positive human sera specimens in the 
collection were obtained from the Nipah virus outbreak investigations conducted in 
Bangladesh in the years 2003, 2004, and 2005.  Since the Bangladesh specimens made up 
81.1% of the entire human sera catalog of 1,727 specimens, the specimens from 
Bangladesh were not over-represented among the 46 Nipah virus antibody positive 
specimens.    
Although many of the Nipah virus seropositive human subjects in the screening 
were likely infected with Nipah virus via person-to-person transmission, the prominent 
modes of transmission varied widely in the previous human Nipah virus outbreaks 
described in the literature review chapter.  Rather than from person-to-person 
transmission, some human cases among the Nipah virus outbreak patients screened 
became infected instead from direct exposure to the Pteropus bat reservoir of Nipah 
virus.  Nipah virus is passed to humans from Pteropus bats through contact with 
environments contaminated with infectious bat secretions or excretions, through direct 
contact with the bats themselves (bats are hunted, killed, and prepared for food in some 
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 Southeast Asian cultures), or through contact with an infected animal intermediary.  The 
case-control studies that investigated the Bangladesh Nipah virus outbreaks indicated that 
regional behaviors associated with increased risk of Nipah virus infection included 
climbing trees near bat roosts or bat foraging sites, drinking a date palm sap beverage, 
and maintaining agricultural zones near bat habitats, as was summarized in Table 1.   
In addition to Nipah virus transmission, these behaviors may put subjects at risk 
of contracting other viruses maintained in Pteropus bat reservoirs.  Pteropus bats in the 
region are the suspected reservoirs of bat orthoreoviruses (such as NB virus) and other 
viruses posing a potentially greater disease risk to humans than orthoreoviruses, such as 
the newly identified lyssaviruses in Australia (similar to rabies virus) or the 
paramyxoviruses Tioman, Menangle, and Hendra viruses.   
 
Interpretation of the Nipah Virus Seroprevalence in the Bat Sera Catalog: 
The catalog of bat sera screened included 2,323 specimens from 27 rare bat 
species indigenous to Southeast Asia.  Pteropus bats are the suspected primary bat 
reservoir of Nipah virus, although non-Pteropus species are also capable of becoming 
infected (Luby et al., 2006).  Previous Nipah virus bat serosurveys have reported 
antibody evidence of Nipah infection in the following species of Megachiropteran bats 
(all within the Pteropodidae family): P. conspicillatus, P. alecto, P. scapulatus, P. 
poliocephalus, P. hypomelanus, P. vampyrus, P. giganteus, P. lylei, Eonycteris spelaea, 
Cynopterus brachyotis, Scotophilus kuhlii, and Hipposideros larvatus (Chua, Koh et al., 
2002; Hsu et al., 2004; Olson et al., 2002).   
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 As was determined by previous testing by Special Pathogens Branch 
microbiologists, Nipah viral antibody was present in the following seven bat species in 
the bat sera catalog: P. giganteus, P. vampyrus, P. rodricensis, P. pumilus, P. lylei,  P. 
hypomelanus, and R. lechenaulti.  Except for the P. rodricensis, P. pumilus, and R. 
lechenaulti species, all species in the catalog with Nipah viral antibody were previously 
reported in the literature as Nipah viral antibody carriers.  The pie chart in Figure 5 
showed that 67% of the 200 Nipah virus antibody positive bats were from the P.  
giganteus and P. vampyrus species, though these two species made up only 30.8% of the 
entire collection.  This fact is not surprising since these bats are suspected to be the 
primary reservoir of Nipah virus in Southeast Asia (Chua, Koh et al., 2002; Hsu et al., 
2004; Olson et al., 2002). 
As is highlighted in yellow in Table 8, note that even though the 168 specimens in 
the 2004 Bangladesh bat cohort made up only 7.2% of the entire bat catalog of 2,323 
specimens, 24.5% of the 200 Nipah virus antibody positive bat specimens belonged to the 
cohort.  Hence, the Bangladesh 2004 cohort of bat specimens was over-represented 
among the 200 Nipah virus antibody positive specimens identified.  The 2004 
Bangladesh bat specimens were collected as part of the ecological serosurveys for Nipah 
virus in bats conducted during the human Nipah virus outbreak investigation in 
Bangladesh in 2004 (Carroll et al., Publication in Preparation).   
There was a greater percentage (29.2%) of Nipah seropositive bats collected from 
Bangladesh in 2004 compared to all other bat specimen groups in the collection.   In 
comparison, only 4.5% of the 44 P. giganteus bats collected in 2003 from Bangladesh 
were Nipah seropositive where as 44.0% of the 109 P. giganteus from Bangladesh in 
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 2004 were seropositive (Carroll et al., Publication in Preparation).  P. giganteus is the 
suspected primary reservoir of Nipah virus in Bangladesh.  There was no difference in 
the percent of P. giganteus bats collected in Bangladesh in 2003 versus 2004 (78.6% of 
the bats collected 2003 were P. giganteus vs. 64.8% in 2004) (T.G. Ksiazek, Personal 
Communication).  Therefore, the difference in Nipah virus antibody prevalence between 
the 2003 and 2004 Bangladesh bat cohorts may be due to factors intrinsic to the 
collection time, location, or sampling method rather than the species composition of the 
bats collected.     
Nipah virus might naturally be more endemic to the area of Bangladesh where the 
2004 cohort of bats were collected due to ecological or geographical factors.  In addition, 
the bats collected in 2004 cohort may have been more strongly associated with a recent 
Nipah virus spillover event into humans resulting from increased Nipah virus prevalence 
in these bats.  Finally, perhaps the timing of specimen collection was related to the 
increase in Nipah virus seroprevalence since the 2004 bats were collected from February 
through May of 2004 while the 2003 bats were all collected in March.  The difference in 
Nipah seroprevalence may be explained by a multitude of factors impossible to tease out 
from the data at hand, none of which are mutually exclusive, or by some yet 
unappreciated determinant.   
 
Implications of the Nelson Bay (NB) Virus EIA Results: 
 No diagnostic test for the presence of NB virus existed prior to this research.  A 
successful EIA was developed to detect NB viral antibody in bats and humans.  
Subsequent serum neutralization testing confirmed that the NB virus antibody positive 
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 specimens detected by the EIA contained antibody capable of neutralizing NB virus.  The 
anti-bat conjugate employed in the NB virus EIA represents the first use of a conjugate 
specifically designed to recognize bats in both the Megachiropteran and Microchiropteran 
suborders.  This conjugate is more sensitive and specific than the conjugate previously 
used in bat serosurveys that merely recognized the protein A and protein G 
immunoglobulin components generic to all mammals (J.B. Oliver, Publication in 
Preparation).  This EIA may be a useful tool for public health professionals to detect 
disease if NB virus, or a closely related virus, spills out of the bat reservoir to cause 
illness in humans, domestic animals, or wildlife.   
This research also represents the first reported attempt to study the prevalence of 
NB virus in wildlife or humans.  No human specimens were NB virus antibody positive 
in the specimen catalog screened.  NB virus antibody was successfully detected in 14 bats 
(0.6%) of three species (R. leschenaulti, P. giganteus, and P. vampyrus) out of the 2,323 
specimens screened.   Thirteen (13) of the 14 NB virus antibody positive bats were 
Rousettus and P. giganteus species and all 13 belonged to the cohort of 168 bat 
specimens collected during the 2004 Bangladesh human Nipah virus outbreak 
investigation.  The only R. leschenaulti specimens in the catalog screened were also 
collected during the 2004 Bangladesh Nipah virus human outbreak investigation.  Ten 
(10) of the 30 (33.3%) R. leschenaulti bats were NB virus antibody positive, as was 
displayed in Table 7.    
 77
  
Interpretation of the Nipah and Nelson Bay (NB) Virus Seroprevalence Pattern 
Similarities: 
 
No human specimens were NB virus antibody positive, so similarities in the 
Nipah and NB virus seroprevalence patterns of were not detected in the human specimen 
catalog.  As was displayed in Table 7, NB virus was successfully detected in three bat 
species (R. leschenaulti, P. giganteus, and P. vampyrus) that also carried antibody to 
Nipah virus.  Therefore, the results support hypothesis (2), which stated that screening the 
bat sera catalog with the newly developed NB virus EIA would result in the successful 
detection of NB viral antibody among bat species in the sera catalog with Nipah viral 
antibody.  The greatest NB virus antibody prevalence was found among the R. 
lechenaulti bats while the greatest Nipah viral seroprevalence was found among the P. 
giganteus bats.   
In the 2004 Bangladesh cohort of 168 bats, the overall antibody prevalence of 
Nipah virus was 29.2% whereas the seroprevalence of NB virus was 7.7%.  One striking 
similarity emerges from comparing the Nipah and NB viral seroprevalence patterns in the 
bat catalog; the 2004 Bangladesh bat cohort had the highest seroprevalence of both NB 
and Nipah viruses.  This fact is very interesting since researchers have suggested that 
environmental conditions may increase the prevalence of zoonotically transmitted viruses 
in bats.  Furthermore, it is interesting that the greater prevalence of Nipah viral antibody 
in the 2004 Bangladesh cohort of bats versus the 2003 Bangladesh cohort was not due to 
differences in the species composition of the bats collected, but rather due to factors 
intrinsic to the to the collection time, location, or sampling method.   
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 The high frequency of human Nipah virus outbreaks in Bangladesh and the 
increased seroprevalence of both Nipah and NB viruses in the 2004 Bangladesh bat 
cohort may provide further evidence of the existence of larger environmental pressures 
that may be affecting the prevalence of bat viruses in the region.  Larger environmental 
factors may also be markers of unbalanced ecosystems.  Therefore, similarities in the 
seroprevalence patterns of bat viruses may be markers of unbalanced ecosystems.   
Unbalanced ecosystems may promote the zoonotic transmission of a range of 
pathogenic agents to humans from many wildlife sources (Alcamo et al., 2003).  
Environmental determinants increasing the prevalence of known viral pathogens in bats 
may similarly be affecting the prevalence levels of viruses yet to be discovered that 
represent an unknown disease risk to human and veterinary public health (van der Poel et 
al., 2006).  Consequently, identifying areas with an increased prevalence of bat viruses 
may allow public health researchers to target surveillance efforts for human diseases to 
appropriate high-risk environments.  Careful monitoring of bat viral prevalence rates may 
also allow public health professionals the opportunity to develop intervention strategies 
to prevent or mitigate human disease outbreaks of bat-transmitted viruses.  
The increased seroprevalence of both Nipah and NB viruses in the 2004 
Bangladesh cohort of bats is confounded by the fact that 10 of the 14 NB virus 
seropositive bats were from the R. leschenaulti species.  The only bats from this species 
in the catalog screened were a part of the Bangladesh 2004 cohort.  Nelson Bay (NB) 
virus may naturally be more prevalent in Rousettus bats than any other species.  
Therefore, it unfortunately cannot be ruled out that the increased seroprevalence of NB 
virus in the 2004 Bangladesh bat cohort was simply due to the presence of Rousettus bats 
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 in the cohort rather than due to the convergence of enabling environmental factors.  Other 
bat sera collections containing specimens from R. leschenaulti bats should be screened 
for NB virus antibody to discern if NB virus is more endemic in the Rousettus species or 
if environmental factors unique to the location where the Bangladesh 2004 cohort of bats 
were collected could be increasing the prevalence of bat viruses in the area.     
   
Interpretation of the Nipah and Nelson Bay (NB) Virus Seroprevalence Results with 
Respect to Mean Measurements of Bat Body Size and Gender: 
 
Of the 120 bats in the 2004 Bangladesh cohort for which gender and body 
measurement data was collected, there was a statistically significant greater mean weight 
(P=0.018) and mean forearm length (P=0.035) in the Nipah virus antibody positive P. 
giganteus males as compared to the seronegative males by independent T-test.  Similarly, 
at the P≤ 0.10 level, there was a statistically significant greater mean forearm length 
(P=0.067) among the NB virus seropositive R. leschenaulti females as compared to the 
seronegative females.   Furthermore, all five of the mean body measurements studied 
were greater among the Nipah virus seropositive P. giganteus males and the NB virus 
seropositive R. leschenaulti females than in the respective seronegative bats, although 
only the mean forearm length and mean weight was statistically significant due to small 
sample size.  These body measurements are used as surrogate measures of age in bats.  
This data implies that Nipah virus antibody positive male P. giganteus bats were more 
likely older than the P. giganteus seronegative male bats and that NB virus antibody 
positive female R. leschenaulti bats were older than the antibody negative females.  There 
was also statistically significant differences in the distribution of Nipah and NB antibody 
by gender within the P. giganteus and R. leschenaulti bats.  The observed differences in 
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 the distribution of bat Nipah and NB viral antibody by gender and by mean body 
measurement may imply that bat mating is a significant source of viral transmission 
among bats.   
Researchers have previously suggested that mating may serve as an important 
source of Nipah virus transmission among bats ("WHO-Wkly Epi Record," 2004).  Only 
older bats mate and males tend to mate with several females in the mating season 
(Elangovan et al., 2002).  Bangladesh Nipah virus human outbreaks have been reported 
yearly since 2003 and all occurred from the months of January through May, which 
coincides with the Bangladesh bat-breeding season ("WHO-Wkly Epi Record," 2004).  
The bat specimens from the 2004 Bangladesh cohort were collected from February 
through May during the breeding season and 92% of the female P. giganteus bats were 
pregnant at the time of specimen collection (Carroll et al., Publication in Preparation).  
Furthermore, earlier Hendra virus studies in Pteropus bats showed an increase in viral 
shedding during bat gestation and parturition, and so Pteropus bats may similarly shed 
more Nipah virus into the environment during this time, resulting in the subsequent 
transmission of Nipah virus to human populations sharing overlapping habitats (Halpin et 
al., 2007; Williamson et al., 1998).  Alternatively, the seasonal cycle of human Nipah 
virus outbreaks in Bangladesh may be associated with seasonal human agricultural 
practices such as the collection of date palm sap from trees, usually occurring from mid-
December through February (Luby et al., 2006), the availability of a seasonal bat food 
source, or some yet unappreciated cyclic risk factor ("WHO-Wkly Epi Record," 2004).    
Conversely, the most likely reason for the statistically significant observed 
increase in the distribution of both Nipah and NB virus seroprevalence among larger (and 
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 inferentially older bats) may simply result from the naturally expected accumulation of 
antibody over time among older bat populations (T.G. Ksiazek, Personal 
Communication).  At the least, since the antibody positive bats were older than the 
negative bats, the antibody detected is likely not merely the result of maternal antibody 
transmission, but rather from individual exposure to these viruses.  If, on the other hand, 
residual maternal antibody were primarily responsible for the Nipah and NB virus 
seroprevalence patterns observed, the antibody positive bats would have smaller mean 
body sizes than the antibody negative bats.  It would be difficult to control for the effects 
of age or other cofounders in field studies examining bat mating and Nipah virus 
transmission since age and the onset of mating behaviors are inextricably linked. 
 
Interpretation of the Nipah and Nelson Bay (NB) Virus Seroprevalence Results with 
Respect to Bat Roost Location: 
 
Forty-two (42) suspected human cases of Nipah virus infection occurred from 
January-February of 2004 in the Rajbari province near the town of Goalando, 
Bangladesh.  The bat specimens in the Bangladesh 2004 cohort were collected near 
Goalando from February-May of 2004 immediately following the human outbreak 
investigation and case-control study.  Among the 126 bats collected from the 11 bat 
roosts, 41 (32.5%) were Nipah virus seropositive while 12 (9.5%) were antibody positive 
for NB virus.  Roosts positive for NB viral antibody were clustered near the Nipah viral 
antibody positive roosts.  Moreover, NB virus antibody positive bats inhabited the same 
roosts as Nipah virus seropositive bats in three of the 11 bat roosts (27.2%) studied.  Out 
of the 13 total NB virus seropositive bats identified in the 2004 Bangladesh cohort, four 
(30.8%) were simultaneously antibody positive for both Nipah and NB viruses.  It can 
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 therefore be concluded that NB virus was circulating in Pteropus and Rousettus 
Megachiropteran fruit bats in Bangladesh at the time of the human Nipah virus outbreak 
and that the habitats of the NB virus seropositive bats potentially overlapped with the 
human settlements containing Nipah virus outbreak patients.   
The case-control study conducted in the 2004 Bangladesh Nipah virus outbreak in 
the town of Goalando by Montgomery et al. determined that environmental exposure to 
bats during activities such as tree climbing were significantly associated with Nipah virus 
infection (Montgomery et al., Publication in Preparation).  This research has 
demonstrated that NB virus was also prevalent in the bats that were the likely source of 
the human Nipah virus infections in 2004.  It can be assumed that humans encounter 
Nipah and NB virus positive bats in a manner that has resulted in the effective 
transmission of Nipah virus from bats to humans.  It is unknown if NB virus is capable of 
infecting humans.  The lack of antibody to NB virus in the human populations screened 
supports the assumption that NB virus has not jumped species to infect humans, despite 
the opportunity for this transmission to occur.  The lack of human NB virus antibody in 
the human specimen catalog was consistent with hypothesis (3), which stated that the 
newly developed EIA would not detect NB viral antibody in the catalog of human 
specimens previously screened for Nipah viral antibody.  It is important for public health 
officials to be aware of the range of viral agents capable of causing human disease to 
effectively investigate outbreaks of unknown etiologies.  This research, which 
investigated if NB virus is capable of infecting humans, is therefore of public health 
importance. 
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 Four of the 13 NB virus antibody positive bats from the Bangladesh 2004 cohort 
were also Nipah virus seropositive.  Furthermore, since Nipah and NB virus antibody 
positive bats shared roosts 1, 2, and 11 (shown in Table 13 and Figure 8), the ecologic 
conditions affecting the prevalence of Nipah virus may also affect the spread of NB virus 
in bats.  It may even be possible for these viruses to co-infect a single bat host 
simultaneously.  The investigators of the 2004 Bangladesh human Nipah virus outbreak 
observed that most bat activity near human Nipah virus cases was limited to foraging for 
food rather than roosting and most of the human cases of Nipah virus infection occurred 
in sites where bats foraged rather than roosted (Carroll et al., Publication in Preparation).  
This may imply that bats transmit Nipah virus to humans while foraging for food.  Bat 
ecologists ascertain that Pteropus bats will forage for cultivated fruit in human 
agricultural settlements when their habitats or food sources are threatened, thereby 
increasing opportunities for human-bat interaction and the transmission of bat viruses via 
saliva on partially eaten fruit or through the contamination of palm sap beverages (Carroll 
et al., Publication in Preparation; van der Poel et al., 2006; Weiss & McMichael, 2004).  
Researchers have suggested that human encroachment in once isolated bat foraging 
habitats contributed to the emergence of the seasonal outbreaks of Nipah viral 
encephalitis in Bangladesh.  Other dynamic environmental factors might similarly be 
altering the ecology of NB virus in bats.   
 
The Public Health Importance of the Results of this Research: 
This research found several similarities in the seroprevalence of both Nipah and 
NB viruses in the cohort of bats collected from Bangladesh in 2004 near the human 
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 settlement that experienced cases of Nipah virus.  The greatest seroprevalence of both 
Nipah and NB viruses was found in the 2004 Bangladesh bat cohort.  The analysis of the 
mean body measurements of the 2004 Bangladesh bat cohort indicated that both the 
Nipah and NB virus seropositive bats were older than the seronegative bats.  Differences 
in the distribution of NB and Nipah viral antibody by bat gender were also detected.  In 
context of the previous Hendra virus transmission studies showing increased viremia 
during bat pregnancy and parturition, this analysis of seroprevalence with respect to mean 
bat body measurements and gender may further support the theory that seasonal bat 
pregnancy is associated with Nipah virus (and possibly NB virus) transmission between 
bats and from bats to humans.  The analysis of seroprevalence with respect to roost 
location of the 2004 Bangladesh bat cohort indicated that the NB virus seropositive bats 
were clustered near the Nipah virus seropositive bats.  Combined with the seasonal 
phenomenon of the Nipah virus outbreaks in Bangladesh, the results generated by this 
research may point to a strong environmental determinant affecting the prevalence of 
both Nipah and NB viruses in Bangladeshi bats.   
An increase in the prevalence of a zoonotically transmitted virus in the bat 
reservoir may represent an increased risk of transmission to humans, potentially leading 
to outbreaks of disease.  Environmental factors increasing the prevalence of viruses in bat 
reservoirs may then be risk factors for the occurrence of human disease.  In addition to 
the two novel orthoreovirus isolates identified by this research, future bat viral ecology 
research will likely discover other bat viruses.  The environmental factors increasing the 
prevalence of the known bat viruses may be similarly affecting the pool of yet 
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 unidentified bat viruses that pose an unknown disease risk to human and veterinary 
public health.   
Environmental risk factors increasing the prevalence of bat viruses may also be 
markers of unbalanced ecosystems.  Unbalanced ecosystems promote the transmission of 
a range of pathogenic agents to humans from many wildlife sources, in addition to bats.  
Understanding the role these risk factors play in promoting disease may allow public 
health officials the opportunity to intervene to prevent bat-transmitted viral illnesses.  
Identifying the environmental risk factors that mark unbalanced ecosystems may also 
allow public health officials to target disease surveillance strategies to appropriate high-
risk environments.  Therefore, identifying the environmental risk factors affecting the 
prevalence of bat viruses is of public health importance.   
 
The Environmental Determinants of Bat Viral Prevalence: 
Several researchers have previously explored the roles environmental 
determinants may play in promoting disease outbreaks of Nipah virus in Southeast Asia.  
As classically depicted by epidemiologic triangle, the role that disease agents, disease 
hosts, and the environment play in the emergence of infectious disease outbreaks is 
particularly well illustrated by the research exploring the environmental causes of the 
Malaysian Nipah virus outbreak.  The El Niño event from 1997-98 in Malaysia was one 
of the strongest of the century (P. R. Epstein et al., 2003; Patz, 2002).  Researchers have 
theorized that the Malaysian monsoon season was upset by this El Niño phenomenon 
resulting in widespread drought, devastating forest fires, and hazardous pollution at the 
time of the Malaysian Nipah virus outbreak (Chua, Chua et al., 2002; P. R. Epstein et al., 
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 2003; Torres-Velez & Brown, 2004).  Some researchers believe that Pteropus fruit bats 
infected with Nipah virus were swept onto Malaysian pig farms encroaching on 
previously uninhabited land while fleeing forest fires fueled by the intense drought 
(Chua, Chua et al., 2002; Daszak et al., 2001; P. R. Epstein et al., 2003; Newman et al., 
2005; Torres-Velez & Brown, 2004).  Concomitantly, a change to modern husbandry 
practices, employing crowded, high-density facilities and the movement of pigs among 
farms, created a convergence of enabling factors that provided the selective pressure 
necessary for Nipah virus to adapt to productively infect humans (J. H. Epstein et al., 
2006; Feldmann et al., 2002; Newman et al., 2005).  Purportedly, the intensity, timing, 
and distribution of extreme weather events, such as the El Niño phenomenon, are 
changing due to global climate change.  These changes could potentially increase the 
worldwide incidence of many human infectious diseases (P. R. Epstein, 2005; P. R. 
Epstein et al., 2003).     
As was noted by Epstein, among others, in his 2001 review in Microbes and 
Infection, “[c]limate is a key determinant of health.  Climate constrains the range of 
infectious diseases, while weather affects the timing and intensity of outbreaks” (P. R. 
Epstein, 2001, p. 747).  In other words, warming trends enable the geographic spread of 
zoonotic and vector borne infections while extreme weather events spawn clusters of 
outbreaks  (P. R. Epstein, 2001; Patz et al., 2004).   
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According to an editorial written by Epstein and colleagues in the 2003 issue of 
Environmental Health Perspectives, 
 “[a]s the climate becomes more unstable, its role [in disease 
emergence] increases.  Having underestimated the rate at which climate 
would change, we are only beginning to understand the responses of 
biological systems to [global] warming and the accompanying 
intensification of weather extremes” (P. R. Epstein et al., 2003, p. A506).   
 
McMichael offered a stunning example of the effects of climate change on 
disease.  He observed that WHO attributed around 6-7% of the world’s malaria cases 
directly to climate change (McMichael, 2004).  Moreover, Patz  (Patz, 2002) recognized 
that scientists at the ICDDR Institute in Bangladesh collected 18 years of data that 
demonstrated a relationship between cholera outbreaks in Bangladesh and increases in 
the sea surface temperature driven by El Niño phenomena (Pascual et al., 2000).  As was 
later reemphasized by Epstein (P. R. Epstein, 2001), the Intergovernmental Panel on 
Climate Change concluded in 2001 that the only means to explain the warming climate of 
close to 1◦C over the 20th century is the heat-trapping role of continuing greenhouse gas 
emissions (Houghton & Intergovernmental Panel on Climate Change. Working Group I., 
2001).   
  Since trends such as global climate change are expected to continue, scientific 
efforts to explore the effects of these environmental risk factors on the appearance of 
infectious diseases, such as Nipah virus, should be intensified.  The Henipavirus Ecology 
Collaborative Research Group is a multinational group of scientists that are using 
Pteropus field and laboratory data to study Nipah and Hendra viral dynamics in the bat 
population.  As described by Daszak et al. (Daszak et al., 2004), they are attempting to 
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 elucidate the roles that climate, deforestation, and anthropogenic landscape change may 
play in virus transmission  (The Henipavirus Ecology Collaborative Research Group). 
Land use change for agricultural purposes was a common denominator in the 
Nipah virus outbreaks in Bangladesh as well as in Malaysia (Fields et al., 2005; Newman 
et al., 2005; van der Poel et al., 2006).  In chapter 18 of Fields Virology entitled 
Emerging Viral Diseases, Peters reminds readers that satellite images show that humans 
have altered over half the earth’s land surface (Fields et al., 2005).  Driven by the needs 
of an increasing human population, global deforestation continues at a rate of nearly three 
percent each year, leading to natural habitat destruction, a loss of species biodiversity, 
and exposure to new pathogens for livestock, wildlife, and ultimately, humans (Daszak et 
al., 2000; McMichael, 2004).  Peters further reiterates that animal extinction rates have 
increased 100 to 1,000 times in recent decades so that many remaining species are 
isolated in small enclaves of genetically homogeneous individuals.  Such selection 
pressures may therefore increase the concentration of EID pathogens in remaining 
populations of animal species (Fields et al., 2005).   
Patz et al. asserted in a 2004 issue of Environmental Health Perspectives that the 
main environmental changes of anthropogenic origin that increase disease emergence risk 
include “deforestation, road construction, agricultural encroachment, dam building, 
irrigation, wetland modification, and mining” (Patz et al., 2004, p. 1092).  McMichael 
additionally included “local/regional weather abnormalities, intensified crop and animal 
production systems, urban sprawl, continued poor sanitation, and the pollution of coastal 
zones” in a version of this list published in his 2004 Philosophical Transactions of the 
Royal Society article (McMichael, 2004, p. 1054).   
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 In summary, Nipah emergence in Southeast Asia may have in part resulted from 
alterations in the movement and population density of Pteropus  bats, brought on by a 
combination of deforestation, drought, and wildfires stemming from global climate 
change (P. R. Epstein et al., 2003; Newman et al., 2005).  Although these environmental 
risk factors are capable of affecting the seroprevalence of Nipah virus and possibly NB 
virus, other factors have certainly played a role in the seasonal detection of Nipah virus in 
Bangladesh.  For example, surveillance efforts to detect human cases of Nipah viral 
infection have intensified in the area since the disease was first reported and more cases 
of Nipah viral encephalitis are likely being recognized.  Since most disease results from a 
complex web of causative factors with biological, socio-behavioral, and environmental 
qualities, it is difficult and sometimes impractical to attribute disease burden to single risk 
component.  If the frequency or severity of Nipah viral outbreaks is indeed increasing in 
Bangladesh, human risk factors, such as a changes in behaviors and diet, bat habitat 
encroachment, new agricultural practices, or changes in the immune status of the local 
population may also be underlying causes of emergence (van der Poel et al., 2006).  
Furthermore, alterations in the virulence or pathogenicity of Nipah virus itself may be 
contributing to the broader disease spectrum observed in recent outbreaks.  
 
Limitations of the Study: 
It is important to qualify this discussion with the caveat that the ecologic 
conditions that affect Nipah viral prevalence may not necessarily similarly affect NB 
viral prevalence in bats since NB virus was more seroprevalent in Rousettus bats while 
more Pteropus bats were Nipah virus antibody positive.  Although classified in the same 
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 taxonomic subfamily, Pteropodinae, Rousettus bats may not share the behavioral 
characteristics of Pteropus bats.  For example, bats of the genus Rousettus are the only 
Megachiropteran bats to use vocal echolocation by producing tongue clicks and therefore 
may have drastically different foraging, roosting, and mating behaviors (Elangovan et al., 
2002).   
A second limitation of this study is that many of the bat and human specimens 
screened were collected during Nipah virus outbreak investigations rather than 
specifically for the purpose of obtaining active surveillance data on the prevalence of bat 
viruses.  Many of the bat species studied are rare or endangered.  If they were available, 
additional specimens from Southeast Asia not associated with outbreaks of Nipah virus 
should be examined to assess the background prevalence of bat viruses in human and bat 
populations.  
 
Recommendations: 
Only 2.7% of the 1,727 total human serum specimens screened were Nipah virus 
seropositive.  As a follow up to this study, Southeast Asian human populations with 
higher Nipah virus seroprevalence levels, and hence a greater level of exposure to the 
reservoir of NB virus, should be screened for NB viral antibody to lend more evidence to 
the conclusion that NB virus lacks the biologic capability to infect humans.  In the 2004 
Bangladesh cohort of 168 bats, the overall antibody prevalence of Nipah virus was 29.2% 
whereas the seroprevalence of NB virus was 7.7%.  An increase in the seroprevalence of 
a bat virus biologically capable of infecting humans may represent an increased risk of 
viral spillover into humans, potentially resulting in human disease (Calisher et al., 2006; 
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 Daszak et al., 2000).  If the Bangladesh bat seroprevalence of NB virus were to increase 
so that it approached the 2004 Nipah virus seroprevalence level, it would be important to 
determine if NB virus antibody could subsequently be detected in Bangladeshi human 
settlements near the antibody positive bats. 
Other CDC researchers have used the bat sera catalog to screen for SARS, Ebola, 
and lyssaviruses since many of the bat species represented in the catalog are rare.  It 
would be worth exploring if any statistically significant patterns in seroprevalence by 
year, location, sex, or body measurement were noted for these viruses as was detected for 
both NB and Nipah viruses in the specimens from Bangladesh in 2004.   
Ideally, long-term bat surveillance studies in Southeast Asia would further 
elucidate the range of viral agents associated with fruit bats and the factors affecting the 
prevalence of bat viruses.  However, active surveillance for viruses in rare bat species 
would prove difficult and unwarranted.  To thoroughly analyze the ecological 
determinants of bat viral prevalence, such surveillance studies should be conducted 
following the framework outlined by the Henipavirus Ecology Collaborative Research 
Group (http://www.henipavirus.org/index.html) and the discipline of conservation 
medicine.  Only through the collaborative efforts of bat ecologists, virologists, and 
infectious disease experts could such surveillance studies definitively identify the 
environmental risk factors affecting the prevalence of bat viruses.   
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Conclusion: 
Given that bats have served as the reservoirs of devastating human illnesses, bat 
viral ecology is an important, yet often underappreciated area of disease research (Breed 
et al., 2005; Calisher et al., 2006; Dobson, 2005; Halpin et al., 2007; Torres-Velez & 
Brown, 2004; van der Poel et al., 2006).  Perhaps other studies like this one will result in 
a greater understanding of bat viral diversity and the factors that affect the prevalence of 
viruses in bats.  Such efforts should help researchers identify the factors that distinguish 
the bat viruses that cause disease in humans from the greater pool of bat viruses that do 
not.  It is likely that there are undiscovered bat viruses with the potential to cause human 
illness since many of the current bat-transmitted diseases are caused by viruses that 
belong to much larger ancient viral families thought to have evolved along with their bat 
hosts (Halpin et al., 2007; S. Wong et al., 2006).   
As noted by Marano et al. in Emerging Infectious Diseases, “episodes of 
emerging zoonoses are being increasingly recognized around the world” (Marano et al., 
2006, p. 1813).  Marano et al. substantiate this claim with data compiled by Cowen et al. 
(Cowen et al., 2006) that “from 1996 to 2004, some 21% of 10,490 reports of animal 
diseases from 191 countries submitted to the Program for Monitoring Emerging 
Infectious Diseases (ProMED) concerned humans affected by zoonotic disease” (Marano 
et al., 2006, p. 1813).  West Nile virus, SARS, monkeypox, and H5N1 avian 
influenza have shown the importance of working closely with the veterinary health 
profession to effectively detect and respond to emerging zoonoses (Chomel & Osburn, 
2006; Torres-Velez & Brown, 2004).  Instead of simply focusing on the next big health 
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 crisis as it arises, researchers must endeavor to look upstream from specific disease risk 
factors to the underlying causes of disease emergence.  Through ecological studies and 
overall species susceptibility investigations, scientists may explore the common 
denominators of disease emergence.  Such research may lead to the identification of 
opportunities for intervention in the transmission of zoonotic diseases to humans (Torres-
Velez & Brown, 2004; Weinhold, 2003) 
Although zoonotic EIDs may not be a leading category of illness in the U.S., their 
perceived exotic nature and high mortality are great sources of concern (McMichael, 
2004).  Exotic zoonotic agents like Nipah virus may be a threat to our public health 
because of their risk to the agricultural industry, threat to the economy, and potential 
bioterrorism use (Kruse et al., 2004).  Many foreign public health agencies have limited 
case management expertise and lack the appropriate resources to safely work with these 
zoonotic agents.  Yet in today’s global environment, one country unable to carry out early 
detection and response to animal disease outbreaks represents a liability to many other 
countries (Farmer, 1996; Zinsstag et al., 2007).  To effectively respond to a potential 
event, the U.S. public health system must renew efforts to support the sophisticated 
infrastructure and trained personnel needed to respond to the spread of an EID outbreak 
(Fauci, 2001; Lederberg et al., 1992).  Many of the social and environmental risk factors 
that contribute to EID spread are outside the traditional focus of the public health sector.  
To respond to the spread of EIDs there will be an increased demand for microbiologists, 
veterinarians, ecologists, epidemiologists, and modelers to work together in 
multidisciplinary teams (Chomel & Osburn, 2006; Davis et al., 2001; Farmer, 1996; 
Newman et al., 2005; Weinhold, 2003).  Therefore, I believe more emphasis should be 
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 placed on the ecological and social aspects of infectious disease emergence in training 
programs for public health professionals following the model outlined by the discipline of 
conservation medicine (McMichael, 2004; Weinhold, 2003).   
In the modern global landscape, the U.S. public health system must be prepared to 
respond to new incidents of global infectious disease to meet the economic, humanitarian, 
and security demands of all people (Fauci, 2005; Lederberg et al., 1992).  As Zinsstag et 
al. concluded in the May 2007 issue of Emerging Infectious Diseases, “[w]hen one 
considers health from a point of view independent of species, including humans, 
domestic animals, and wildlife, zoonoses are part of a broader ecologic concept of health 
systems” (Zinsstag et al., 2007, p. 527).  I believe adopting this ecologic viewpoint of 
health will be a critical asset for public health professionals working to control the spread 
of EIDs in the future. 
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